role - Ontology Report - Rat Genome Database

Help | FTP Download | Citing RGD | Contact Us

Keyword

ONTOLOGY REPORT - ANNOTATIONS

Term:	role	go back to main search page
Accession:	CHEBI:50906	browse the term
Definition:	A role is particular behaviour which a material entity may exhibit.

Rat
Mouse
Human
All
show annotations for term's descendants
Sort by:

1,2-didecanoylglycerol
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Sprr1a	small proline-rich protein 1A		increases expression	ISO	2	185,463,951	185,465,849	RGD:6480464	CTD
1,2-dilauroyl-sn-glycero-3-phosphocholine
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cyp3a2	cytochrome P450, family 3, subfamily a, polypeptide 2		multiple interactions	ISO	12	9,517,016	9,541,000	RGD:6480464	CTD
G	Cyp3a2	cytochrome P450, family 3, subfamily a, polypeptide 2		multiple interactions	EXP	12	9,517,016	9,541,000	RGD:6480464	CTD
G	Pon1	paraoxonase 1		increases activity	ISO	4	29,936,314	29,964,821	RGD:6480464	CTD
1-O-palmitoyl-2-O-arachidonoyl-sn-glycero-3-phosphocholine
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Lipg	lipase, endothelial		increases hydrolysis	ISO	18	71,795,150	71,816,056	RGD:6480464	CTD
1D-myo-inositol 1-phosphate
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ppargc1a	peroxisome proliferator-activated receptor gamma, coactivator 1 alpha		increases expression	ISO	14	64,278,115	64,370,912	RGD:6480464	CTD
2-arachidonoylglycerol
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Abhd12	abhydrolase domain containing 12		increases hydrolysis	ISO	3	141,468,888	141,530,219	RGD:6480464	CTD
G	Abhd6	abhydrolase domain containing 6		increases hydrolysis	ISO	15	18,846,512	18,894,003	RGD:6480464	CTD
G	Ccl2	chemokine (C-C motif) ligand 2		increases expression	ISO	10	70,256,263	70,258,061	RGD:6480464	CTD
G	Ces2h	carboxylesterase 2H		increases hydrolysis	ISO	19	34,910,981	34,925,547	RGD:6480464	CTD
G	Ces2h	carboxylesterase 2H		multiple interactions	ISO	19	34,910,981	34,925,547	RGD:6480464	CTD
G	Cnr1	cannabinoid receptor 1 (brain)		increases expression	EXP	5	50,427,173	50,445,471	RGD:6480464	CTD
G	Cnr1	cannabinoid receptor 1 (brain)		increases expression	EXP	5	50,427,173	50,445,471	RGD:6480464	CTD
G	Cnr1	cannabinoid receptor 1 (brain)		multiple interactions	EXP	5	50,427,173	50,445,471	RGD:6480464	CTD
G	Cnr1	cannabinoid receptor 1 (brain)		multiple interactions	EXP	5	50,427,173	50,445,471	RGD:6480464	CTD
G	Cnr1	cannabinoid receptor 1 (brain)		multiple interactions	ISO	5	50,427,173	50,445,471	RGD:6480464	CTD
G	Cnr1	cannabinoid receptor 1 (brain)		increases expression	EXP	5	50,427,173	50,445,471	RGD:6480464	CTD
G	Cnr2	cannabinoid receptor 2 (macrophage)		multiple interactions	ISO	5	154,674,754	154,702,552	RGD:6480464	CTD
G	Cnr2	cannabinoid receptor 2 (macrophage)		multiple interactions	ISO	5	154,674,754	154,702,552	RGD:6480464	CTD
G	Cnr2	cannabinoid receptor 2 (macrophage)		affects response to substance	ISO	5	154,674,754	154,702,552	RGD:6480464	CTD
G	Fmr1	fragile X mental retardation 1		multiple interactions	ISO	X	154,756,031	154,793,782	RGD:6480464	CTD
G	Fyn	FYN oncogene related to SRC, FGR, YES		multiple interactions	EXP	20	43,501,853	43,695,567	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		decreases expression	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il2	interleukin 2		multiple interactions	ISO	2	123,655,005	123,659,709	RGD:6480464	CTD
G	Il6	interleukin 6		decreases expression	ISO	4	456,799	461,376	RGD:6480464	CTD
G	Map2k1	mitogen activated protein kinase kinase 1		multiple interactions	EXP	8	68,379,074	68,451,554	RGD:6480464	CTD
G	Map2k2	mitogen activated protein kinase kinase 2		multiple interactions	EXP	7	10,074,654	10,094,003	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	EXP	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	EXP	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mgll	monoglyceride lipase		increases hydrolysis	ISO	4	122,822,493	122,922,892	RGD:6480464	CTD
G	Mgll	monoglyceride lipase		multiple interactions	EXP	4	122,822,493	122,922,892	RGD:6480464	CTD
G	Mgll	monoglyceride lipase		increases hydrolysis	EXP	4	122,822,493	122,922,892	RGD:6480464	CTD
G	Mgll	monoglyceride lipase		multiple interactions	ISO	4	122,822,493	122,922,892	RGD:6480464	CTD
G	Potef	POTE ankyrin domain family, member F		increases expression	EXP	18	24,420,779	24,422,284	RGD:6480464	CTD
G	Potef	POTE ankyrin domain family, member F		multiple interactions	EXP	18	24,420,779	24,422,284	RGD:6480464	CTD
G	Pparg	peroxisome proliferator-activated receptor gamma		affects binding	ISO	4	151,492,220	151,617,331	RGD:6480464	CTD
G	Pparg	peroxisome proliferator-activated receptor gamma		increases expression	ISO	4	151,492,220	151,617,331	RGD:6480464	CTD
G	Pparg	peroxisome proliferator-activated receptor gamma		multiple interactions	ISO	4	151,492,220	151,617,331	RGD:6480464	CTD
G	Ptgs1	prostaglandin-endoperoxide synthase 1		multiple interactions	EXP	3	15,343,832	15,365,412	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		increases metabolic processing	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		decreases expression	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Trpv1	transient receptor potential cation channel, subfamily V, member 1		multiple interactions	EXP	10	60,109,656	60,134,939	RGD:6480464	CTD
acetylcholine
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Abcc8	ATP-binding cassette, subfamily C (CFTR/MRP), member 8		multiple interactions	EXP	1	96,622,574	96,703,723	RGD:6480464	CTD
G	Ache	acetylcholinesterase		multiple interactions	ISO				RGD:6480464	CTD
G	Ache	acetylcholinesterase		increases abundance	ISO				RGD:6480464	CTD
G	Ache	acetylcholinesterase		affects abundance	ISO				RGD:6480464	CTD
G	Ache	acetylcholinesterase		multiple interactions	EXP				RGD:6480464	CTD
G	Ache	acetylcholinesterase		increases hydrolysis	ISO				RGD:6480464	CTD
G	Ache	acetylcholinesterase		increases activity	EXP				RGD:6480464	CTD
G	Adcy5	adenylate cyclase 5		increases response to substance	ISO	11	67,290,968	67,437,468	RGD:6480464	CTD
G	Adora2a	adenosine A2a receptor		increases response to substance	EXP	20	13,815,719	13,834,131	RGD:6480464	CTD
G	Adora2a	adenosine A2a receptor		multiple interactions	EXP	20	13,815,719	13,834,131	RGD:6480464	CTD
G	Adra2b	adrenoceptor alpha 2B		multiple interactions	ISO	3	114,867,357	114,869,680	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		multiple interactions	ISO	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		decreases response to substance	ISO	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		decreases response to substance	ISO	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		multiple interactions	ISO	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Alox15	arachidonate 15-lipoxygenase		multiple interactions	ISO	10	57,185,939	57,194,388	RGD:6480464	CTD
G	Apoe	apolipoprotein E		affects response to substance	ISO	1	79,003,634	79,006,387	RGD:6480464	CTD
G	App	amyloid beta (A4) precursor protein		multiple interactions	ISO	11	24,457,855	24,693,851	RGD:6480464	CTD
G	App	amyloid beta (A4) precursor protein		multiple interactions	EXP	11	24,457,855	24,693,851	RGD:6480464	CTD
G	App	amyloid beta (A4) precursor protein		decreases secretion	ISO	11	24,457,855	24,693,851	RGD:6480464	CTD
G	Atp7a	ATPase, Cu++ transporting, alpha polypeptide		multiple interactions	ISO	X	94,192,540	94,249,776	RGD:6480464	CTD
G	Bche	butyrylcholinesterase		increases degradation	ISO	2	164,329,613	164,427,994	RGD:6480464	CTD
G	Bche	butyrylcholinesterase		multiple interactions	ISO	2	164,329,613	164,427,994	RGD:6480464	CTD
G	Calca	calcitonin-related polypeptide alpha		multiple interactions	EXP	1	172,686,168	172,691,061	RGD:6480464	CTD
G	Calca	calcitonin-related polypeptide alpha		increases response to substance	EXP	1	172,686,168	172,691,061	RGD:6480464	CTD
G	Cav1	caveolin 1, caveolae protein		multiple interactions	ISO	4	42,956,102	42,989,057	RGD:6480464	CTD
G	Chrm1	cholinergic receptor, muscarinic 1		increases activity	ISO	1	211,351,738	211,353,120	RGD:6480464	CTD
G	Chrm1	cholinergic receptor, muscarinic 1		multiple interactions	ISO	1	211,351,738	211,353,120	RGD:6480464	CTD
G	Chrm1	cholinergic receptor, muscarinic 1		increases activity	EXP	1	211,351,738	211,353,120	RGD:6480464	CTD
G	Chrm1	cholinergic receptor, muscarinic 1		multiple interactions	EXP	1	211,351,738	211,353,120	RGD:6480464	CTD
G	Chrm1	cholinergic receptor, muscarinic 1		multiple interactions	EXP	1	211,351,738	211,353,120	RGD:6480464	CTD
G	Chrm1	cholinergic receptor, muscarinic 1		affects binding	ISO	1	211,351,738	211,353,120	RGD:6480464	CTD
G	Chrm1	cholinergic receptor, muscarinic 1		multiple interactions	ISO	1	211,351,738	211,353,120	RGD:6480464	CTD
G	Chrm1	cholinergic receptor, muscarinic 1		multiple interactions	ISO	1	211,351,738	211,353,120	RGD:6480464	CTD
G	Chrm1	cholinergic receptor, muscarinic 1		multiple interactions	ISO	1	211,351,738	211,353,120	RGD:6480464	CTD
G	Chrm1	cholinergic receptor, muscarinic 1		multiple interactions	ISO	1	211,351,738	211,353,120	RGD:6480464	CTD
G	Chrm1	cholinergic receptor, muscarinic 1		affects binding	ISO	1	211,351,738	211,353,120	RGD:6480464	CTD
G	Chrm2	cholinergic receptor, muscarinic 2		multiple interactions	ISO	4	63,911,292	63,913,354	RGD:6480464	CTD
G	Chrm2	cholinergic receptor, muscarinic 2		affects binding	ISO	4	63,911,292	63,913,354	RGD:6480464	CTD
G	Chrm2	cholinergic receptor, muscarinic 2		multiple interactions	ISO	4	63,911,292	63,913,354	RGD:6480464	CTD
G	Chrm2	cholinergic receptor, muscarinic 2		affects binding	ISO	4	63,911,292	63,913,354	RGD:6480464	CTD
G	Chrm2	cholinergic receptor, muscarinic 2		multiple interactions	ISO	4	63,911,292	63,913,354	RGD:6480464	CTD
G	Chrm3	cholinergic receptor, muscarinic 3		increases response to substance	ISO	17	71,214,906	71,218,463	RGD:6480464	CTD
G	Chrm3	cholinergic receptor, muscarinic 3		increases activity	EXP	17	71,214,906	71,218,463	RGD:6480464	CTD
G	Chrm3	cholinergic receptor, muscarinic 3		multiple interactions	EXP	17	71,214,906	71,218,463	RGD:6480464	CTD
G	Chrm3	cholinergic receptor, muscarinic 3		multiple interactions	ISO	17	71,214,906	71,218,463	RGD:6480464	CTD
G	Chrm3	cholinergic receptor, muscarinic 3		multiple interactions	ISO	17	71,214,906	71,218,463	RGD:6480464	CTD
G	Chrm3	cholinergic receptor, muscarinic 3		affects binding	ISO	17	71,214,906	71,218,463	RGD:6480464	CTD
G	Chrm3	cholinergic receptor, muscarinic 3		multiple interactions	ISO	17	71,214,906	71,218,463	RGD:6480464	CTD
G	Chrm3	cholinergic receptor, muscarinic 3		multiple interactions	ISO	17	71,214,906	71,218,463	RGD:6480464	CTD
G	Chrm3	cholinergic receptor, muscarinic 3		affects binding	ISO	17	71,214,906	71,218,463	RGD:6480464	CTD
G	Chrm3	cholinergic receptor, muscarinic 3		affects binding	EXP	17	71,214,906	71,218,463	RGD:6480464	CTD
G	Chrm3	cholinergic receptor, muscarinic 3		multiple interactions	EXP	17	71,214,906	71,218,463	RGD:6480464	CTD
G	Chrm4	cholinergic receptor, muscarinic 4		multiple interactions	ISO	3	76,301,988	76,309,729	RGD:6480464	CTD
G	Chrm4	cholinergic receptor, muscarinic 4		multiple interactions	ISO	3	76,301,988	76,309,729	RGD:6480464	CTD
G	Chrm4	cholinergic receptor, muscarinic 4		affects binding	ISO	3	76,301,988	76,309,729	RGD:6480464	CTD
G	Chrm4	cholinergic receptor, muscarinic 4		multiple interactions	ISO	3	76,301,988	76,309,729	RGD:6480464	CTD
G	Chrm4	cholinergic receptor, muscarinic 4		multiple interactions	ISO	3	76,301,988	76,309,729	RGD:6480464	CTD
G	Chrm4	cholinergic receptor, muscarinic 4		affects binding	ISO	3	76,301,988	76,309,729	RGD:6480464	CTD
G	Chrm4	cholinergic receptor, muscarinic 4		multiple interactions	ISO	3	76,301,988	76,309,729	RGD:6480464	CTD
G	Chrm5	cholinergic receptor, muscarinic 5		affects response to substance	ISO	3	98,326,809	98,378,531	RGD:6480464	CTD
G	Chrm5	cholinergic receptor, muscarinic 5		decreases response to substance	ISO	3	98,326,809	98,378,531	RGD:6480464	CTD
G	Chrna1	cholinergic receptor, nicotinic, alpha 1 (muscle)		multiple interactions	ISO	3	56,087,754	56,102,821	RGD:6480464	CTD
G	Chrna1	cholinergic receptor, nicotinic, alpha 1 (muscle)		multiple interactions	ISO	3	56,087,754	56,102,821	RGD:6480464	CTD
G	Chrna1	cholinergic receptor, nicotinic, alpha 1 (muscle)		multiple interactions	EXP	3	56,087,754	56,102,821	RGD:6480464	CTD
G	Chrna10	cholinergic receptor, nicotinic, alpha 10 (neuronal)		multiple interactions	ISO	1	159,590,904	159,595,101	RGD:6480464	CTD
G	Chrna2	cholinergic receptor, nicotinic, alpha 2 (neuronal)		multiple interactions	ISO	15	45,570,809	45,587,091	RGD:6480464	CTD
G	Chrna2	cholinergic receptor, nicotinic, alpha 2 (neuronal)		affects response to substance	ISO	15	45,570,809	45,587,091	RGD:6480464	CTD
G	Chrna2	cholinergic receptor, nicotinic, alpha 2 (neuronal)		multiple interactions	ISO	15	45,570,809	45,587,091	RGD:6480464	CTD
G	Chrna2	cholinergic receptor, nicotinic, alpha 2 (neuronal)		multiple interactions	EXP	15	45,570,809	45,587,091	RGD:6480464	CTD
G	Chrna3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		multiple interactions	EXP	8	58,570,223	58,583,594	RGD:6480464	CTD
G	Chrna3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		multiple interactions	ISO	8	58,570,223	58,583,594	RGD:6480464	CTD
G	Chrna3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		multiple interactions	ISO	8	58,570,223	58,583,594	RGD:6480464	CTD
G	Chrna3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		multiple interactions	EXP	8	58,570,223	58,583,594	RGD:6480464	CTD
G	Chrna3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		multiple interactions	ISO	8	58,570,223	58,583,594	RGD:6480464	CTD
G	Chrna3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		multiple interactions	ISO	8	58,570,223	58,583,594	RGD:6480464	CTD
G	Chrna3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		multiple interactions	ISO	8	58,570,223	58,583,594	RGD:6480464	CTD
G	Chrna3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		multiple interactions	EXP	8	58,570,223	58,583,594	RGD:6480464	CTD
G	Chrna3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		multiple interactions	ISO	8	58,570,223	58,583,594	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	EXP	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		increases response to substance	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	EXP	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		affects binding	EXP	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	EXP	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	EXP	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	EXP	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	3	170,171,214	170,185,998	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		increases activity	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		increases activity	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		multiple interactions	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		multiple interactions	EXP	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		increases activity	EXP	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		multiple interactions	EXP	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		increases activity	EXP	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		increases activity	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		multiple interactions	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		increases activity	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		multiple interactions	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		multiple interactions	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		increases activity	ISO	1	117,587,580	117,716,267	RGD:6480464	CTD
G	Chrna9	cholinergic receptor, nicotinic, alpha 9 (neuronal)		multiple interactions	ISO	14	44,906,566	44,913,821	RGD:6480464	CTD
G	Chrnb1	cholinergic receptor, nicotinic, beta 1 (muscle)		multiple interactions	ISO	10	56,604,907	56,617,423	RGD:6480464	CTD
G	Chrnb1	cholinergic receptor, nicotinic, beta 1 (muscle)		multiple interactions	ISO	10	56,604,907	56,617,423	RGD:6480464	CTD
G	Chrnb1	cholinergic receptor, nicotinic, beta 1 (muscle)		multiple interactions	EXP	10	56,604,907	56,617,423	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	EXP	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		affects binding	EXP	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	EXP	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	EXP	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	EXP	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	EXP	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	EXP	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb2	cholinergic receptor, nicotinic, beta 2 (neuronal)		multiple interactions	ISO	2	181,961,373	181,969,581	RGD:6480464	CTD
G	Chrnb4	cholinergic receptor, nicotinic, beta 4 (neuronal)		multiple interactions	EXP	8	58,586,961	58,605,545	RGD:6480464	CTD
G	Chrnb4	cholinergic receptor, nicotinic, beta 4 (neuronal)		multiple interactions	ISO	8	58,586,961	58,605,545	RGD:6480464	CTD
G	Chrnb4	cholinergic receptor, nicotinic, beta 4 (neuronal)		multiple interactions	ISO	8	58,586,961	58,605,545	RGD:6480464	CTD
G	Chrnb4	cholinergic receptor, nicotinic, beta 4 (neuronal)		multiple interactions	ISO	8	58,586,961	58,605,545	RGD:6480464	CTD
G	Chrnb4	cholinergic receptor, nicotinic, beta 4 (neuronal)		multiple interactions	ISO	8	58,586,961	58,605,545	RGD:6480464	CTD
G	Chrnb4	cholinergic receptor, nicotinic, beta 4 (neuronal)		multiple interactions	EXP	8	58,586,961	58,605,545	RGD:6480464	CTD
G	Chrnd	cholinergic receptor, nicotinic, delta (muscle)		multiple interactions	ISO	9	85,996,421	86,004,839	RGD:6480464	CTD
G	Chrnd	cholinergic receptor, nicotinic, delta (muscle)		multiple interactions	EXP	9	85,996,421	86,004,839	RGD:6480464	CTD
G	Chrnd	cholinergic receptor, nicotinic, delta (muscle)		multiple interactions	ISO	9	85,996,421	86,004,839	RGD:6480464	CTD
G	Chrne	cholinergic receptor, nicotinic, epsilon (muscle)		multiple interactions	ISO	10	57,497,192	57,501,511	RGD:6480464	CTD
G	Chrne	cholinergic receptor, nicotinic, epsilon (muscle)		multiple interactions	ISO	10	57,497,192	57,501,511	RGD:6480464	CTD
G	Chrne	cholinergic receptor, nicotinic, epsilon (muscle)		multiple interactions	EXP	10	57,497,192	57,501,511	RGD:6480464	CTD
G	Chrng	cholinergic receptor, nicotinic, gamma (muscle)		multiple interactions	EXP	9	86,012,089	86,018,199	RGD:6480464	CTD
G	Chrng	cholinergic receptor, nicotinic, gamma (muscle)		multiple interactions	ISO	9	86,012,089	86,018,199	RGD:6480464	CTD
G	Crh	corticotropin releasing hormone		increases expression	EXP	2	104,764,023	104,765,887	RGD:6480464	CTD
G	Csf2	colony stimulating factor 2 (granulocyte-macrophage)		increases secretion	ISO	10	39,665,850	39,667,831	RGD:6480464	CTD
G	Cybb	cytochrome b-245, beta polypeptide		multiple interactions	ISO	X	25,514,572	25,547,181	RGD:6480464	CTD
G	Edn1	endothelin 1		decreases response to substance	EXP	17	28,303,886	28,309,775	RGD:6480464	CTD
G	Edn1	endothelin 1		multiple interactions	EXP	17	28,303,886	28,309,775	RGD:6480464	CTD
G	Esr1	estrogen receptor 1		multiple interactions	ISO	1	35,523,680	35,759,891	RGD:6480464	CTD
G	Fbn1	fibrillin 1		multiple interactions	ISO	3	112,608,480	112,804,118	RGD:6480464	CTD
G	Fkbp1b	FK506 binding protein 1b		multiple interactions	ISO				RGD:6480464	CTD
G	Gch1	GTP cyclohydrolase 1		multiple interactions	EXP	15	23,023,996	23,139,794	RGD:6480464	CTD
G	Gclc	glutamate-cysteine ligase, catalytic subunit		decreases response to substance	ISO	8	82,724,429	82,762,848	RGD:6480464	CTD
G	Gclm	glutamate cysteine ligase, modifier subunit		affects response to substance	ISO	2	218,895,434	218,915,491	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		affects response to substance	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		multiple interactions	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		increases secretion	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1rn	interleukin 1 receptor antagonist		affects response to substance	ISO	3	2,607,800	2,613,216	RGD:6480464	CTD
G	Il5	interleukin 5		increases response to substance	ISO	10	39,177,786	39,180,657	RGD:6480464	CTD
G	Il5ra	interleukin 5 receptor, alpha		increases response to substance	ISO	4	142,067,108	142,098,051	RGD:6480464	CTD
G	Il5ra	interleukin 5 receptor, alpha		affects response to substance	ISO	4	142,067,108	142,098,051	RGD:6480464	CTD
G	Il5ra	interleukin 5 receptor, alpha		affects response to substance	ISO	4	142,067,108	142,098,051	RGD:6480464	CTD
G	Kcnj8	potassium inwardly-rectifying channel, subfamily J, member 8		multiple interactions	EXP	4	180,144,084	180,149,935	RGD:6480464	CTD
G	Lepr	leptin receptor		decreases response to substance	ISO	5	122,320,075	122,503,449	RGD:6480464	CTD
G	Lepr	leptin receptor		multiple interactions	ISO	5	122,320,075	122,503,449	RGD:6480464	CTD
G	Lpl	lipoprotein lipase		affects response to substance	ISO	16	22,533,105	22,556,905	RGD:6480464	CTD
G	Mmp9	matrix metallopeptidase 9		affects response to substance	ISO	3	155,985,473	155,993,433	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		multiple interactions	ISO	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		affects response to substance	ISO	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		increases response to substance	ISO	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		multiple interactions	EXP	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Pkd1	polycystic kidney disease 1 homolog (human)		affects response to substance	ISO	10	13,801,445	13,848,212	RGD:6480464	CTD
G	Pomc	proopiomelanocortin		increases expression	EXP	6	26,931,969	26,937,789	RGD:6480464	CTD
G	Pomc	proopiomelanocortin		multiple interactions	EXP	6	26,931,969	26,937,789	RGD:6480464	CTD
G	Sigmar1	sigma non-opioid intracellular receptor 1		multiple interactions	EXP	5	59,162,537	59,165,315	RGD:6480464	CTD
G	Slc17a8	solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8		affects secretion	ISO	7	26,361,488	26,413,820	RGD:6480464	CTD
G	Sod1	superoxide dismutase 1, soluble		affects activity	EXP	11	29,810,766	29,816,342	RGD:6480464	CTD
G	Sod2	superoxide dismutase 2, mitochondrial		multiple interactions	ISO	1	41,862,997	41,870,327	RGD:6480464	CTD
G	Sod2	superoxide dismutase 2, mitochondrial		affects response to substance	ISO	1	41,862,997	41,870,327	RGD:6480464	CTD
G	Tac1	tachykinin, precursor 1		multiple interactions	EXP	4	32,649,666	32,657,632	RGD:6480464	CTD
G	Tac1	tachykinin, precursor 1		affects abundance	EXP	4	32,649,666	32,657,632	RGD:6480464	CTD
G	Thrb	thyroid hormone receptor beta		affects response to substance	ISO	15	9,282,845	9,345,506	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Trpc6	transient receptor potential cation channel, subfamily C, member 6		multiple interactions	EXP	8	5,472,515	5,577,537	RGD:6480464	CTD
G	Vim	vimentin		multiple interactions	ISO	17	87,847,280	87,855,763	RGD:6480464	CTD
angiotensin II
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Agtr2	angiotensin II receptor, type 2		increases expression	EXP				RGD:6480464	CTD
G	Ednrb	endothelin receptor type B		increases expression	EXP	15	87,893,141	87,898,700	RGD:6480464	CTD
argipressin
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Hspb1	heat shock protein 1		increases expression	EXP	12	21,911,223	21,912,784	RGD:6480464	CTD
G	Hspb1	heat shock protein 1		multiple interactions	EXP	12	21,911,223	21,912,784	RGD:6480464	CTD
G	Myl9	myosin, light chain 9, regulatory		increases phosphorylation	EXP	3	147,190,252	147,193,865	RGD:6480464	CTD
G	Nppa	natriuretic peptide A		decreases response to substance	ISO	5	165,074,518	165,075,827	RGD:6480464	CTD
calcitonin
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Hcrt	hypocretin		decreases expression	EXP	10	89,699,633	89,700,847	RGD:6480464	CTD
G	Pmch	pro-melanin-concentrating hormone		decreases expression	EXP	7	24,778,133	24,779,449	RGD:6480464	CTD
corticosterone
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Oplah	5-oxoprolinase (ATP-hydrolysing)		increases expression	EXP	7	114,326,739	114,341,949	RGD:6480464	CTD
G	Pck2	phosphoenolpyruvate carboxykinase 2 (mitochondrial)		decreases expression	EXP	15	33,671,834	33,680,613	RGD:6480464	CTD
G	Pcna	proliferating cell nuclear antigen		decreases expression	EXP	3	120,008,715	120,012,589	RGD:6480464	CTD
corticotropin
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ada	adenosine deaminase		increases activity	ISO	3	154,636,530	154,660,637	RGD:6480464	CTD
G	Calca	calcitonin-related polypeptide alpha		increases abundance	EXP	1	172,686,168	172,691,061	RGD:6480464	CTD
G	Cnp	2',3'-cyclic nucleotide 3' phosphodiesterase		decreases activity	EXP	10	89,519,421	89,525,978	RGD:6480464	CTD
G	Crh	corticotropin releasing hormone		multiple interactions	EXP	2	104,764,023	104,765,887	RGD:6480464	CTD
G	Crh	corticotropin releasing hormone		increases secretion	EXP	2	104,764,023	104,765,887	RGD:6480464	CTD
G	Gh1	growth hormone 1		multiple interactions	ISO	10	95,692,240	95,694,117	RGD:6480464	CTD
G	Htr2a	5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled		multiple interactions	EXP	15	55,463,743	55,532,293	RGD:6480464	CTD
G	Htr2a	5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled		affects expression	EXP	15	55,463,743	55,532,293	RGD:6480464	CTD
G	Ins2	insulin 2		multiple interactions	ISO	1	202,935,548	202,936,379	RGD:6480464	CTD
G	Nr3c1	nuclear receptor subfamily 3, group C, member 1		affects abundance	ISO	18	32,371,496	32,459,145	RGD:6480464	CTD
G	Ppp1r1b	protein phosphatase 1, regulatory (inhibitor) subunit 1B		multiple interactions	ISO	10	87,121,889	87,131,587	RGD:6480464	CTD
G	Ucn2	urocortin 2		increases abundance	ISO	8	114,003,817	114,005,366	RGD:6480464	CTD
D-mannitol
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Abcb1a	ATP-binding cassette, sub-family B (MDR/TAP), member 1A		multiple interactions	EXP	4	21,709,855	21,796,628	RGD:6480464	CTD
G	Bad	BCL2-associated agonist of cell death		increases phosphorylation	EXP	1	209,617,373	209,626,292	RGD:6480464	CTD
G	Bad	BCL2-associated agonist of cell death		multiple interactions	EXP	1	209,617,373	209,626,292	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		increases expression	EXP	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases activity	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases activity	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp9	caspase 9, apoptosis-related cysteine peptidase		increases activity	ISO	5	160,704,234	160,721,796	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		increases expression	ISO	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Igf1	insulin-like growth factor 1		multiple interactions	ISO	7	24,531,669	24,605,742	RGD:6480464	CTD
G	Jun	jun proto-oncogene		increases expression	EXP	5	115,358,166	115,361,259	RGD:6480464	CTD
G	Map2k1	mitogen activated protein kinase kinase 1		multiple interactions	EXP	8	68,379,074	68,451,554	RGD:6480464	CTD
G	Map2k2	mitogen activated protein kinase kinase 2		multiple interactions	EXP	7	10,074,654	10,094,003	RGD:6480464	CTD
G	Myl9	myosin, light chain 9, regulatory		decreases phosphorylation	EXP	3	147,190,252	147,193,865	RGD:6480464	CTD
G	Nppa	natriuretic peptide A		increases expression	ISO	5	165,074,518	165,075,827	RGD:6480464	CTD
G	Oat	ornithine aminotransferase		multiple interactions	EXP	1	192,026,623	192,046,404	RGD:6480464	CTD
G	Pdcd4	programmed cell death 4		increases expression	ISO	1	260,183,648	260,202,032	RGD:6480464	CTD
G	Pdcd4	programmed cell death 4		decreases expression	ISO	1	260,183,648	260,202,032	RGD:6480464	CTD
G	Ptk2	protein tyrosine kinase 2		multiple interactions	ISO	7	110,933,298	111,084,554	RGD:6480464	CTD
G	Slc12a1	solute carrier family 12 (sodium/potassium/chloride transporters), member 1		increases activity	EXP	3	112,455,897	112,534,752	RGD:6480464	CTD
G	Slc12a1	solute carrier family 12 (sodium/potassium/chloride transporters), member 1		multiple interactions	EXP	3	112,455,897	112,534,752	RGD:6480464	CTD
G	Src	v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)		multiple interactions	EXP	3	148,157,256	148,170,524	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tpd52	tumor protein D52		decreases expression	ISO	2	94,850,203	94,880,802	RGD:6480464	CTD
G	Tpd52	tumor protein D52		increases expression	ISO	2	94,850,203	94,880,802	RGD:6480464	CTD
dioleoyl phosphatidylcholine
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cyp3a2	cytochrome P450, family 3, subfamily a, polypeptide 2		multiple interactions	ISO	12	9,517,016	9,541,000	RGD:6480464	CTD
G	Cyp3a2	cytochrome P450, family 3, subfamily a, polypeptide 2		multiple interactions	EXP	12	9,517,016	9,541,000	RGD:6480464	CTD
G	Lcat	lecithin cholesterol acyltransferase		affects binding	ISO	19	35,781,507	35,784,966	RGD:6480464	CTD
G	Pon1	paraoxonase 1		multiple interactions	ISO	4	29,936,314	29,964,821	RGD:6480464	CTD
dipalmitoyl phosphatidylglycerol
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Pon1	paraoxonase 1		multiple interactions	ISO	4	29,936,314	29,964,821	RGD:6480464	CTD
glycerol
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ada	adenosine deaminase		multiple interactions	ISO	3	154,636,530	154,660,637	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		increases abundance	EXP	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		multiple interactions	EXP	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Akt1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	ISO	6	137,640,482	137,657,552	RGD:6480464	CTD
G	Akt1	v-akt murine thymoma viral oncogene homolog 1		increases phosphorylation	ISO	6	137,640,482	137,657,552	RGD:6480464	CTD
G	Angptl4	angiopoietin-like 4		affects abundance	ISO	7	16,261,623	16,267,852	RGD:6480464	CTD
G	Apoa1	apolipoprotein A-I		multiple interactions	ISO				RGD:6480464	CTD
G	Aqp9	aquaporin 9		increases abundance	ISO	8	75,611,485	75,651,646	RGD:6480464	CTD
G	Aqp9	aquaporin 9		multiple interactions	ISO	8	75,611,485	75,651,646	RGD:6480464	CTD
G	Cyp2e1	cytochrome P450, family 2, subfamily e, polypeptide 1		multiple interactions	ISO	1	200,918,521	200,928,919	RGD:6480464	CTD
G	Gk	glycerol kinase		multiple interactions	EXP	X	72,416,872	72,493,296	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		increases expression	ISO	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Mgll	monoglyceride lipase		increases chemical synthesis	EXP	4	122,822,493	122,922,892	RGD:6480464	CTD
G	Mgll	monoglyceride lipase		multiple interactions	EXP	4	122,822,493	122,922,892	RGD:6480464	CTD
G	Mt1a	metallothionein 1a		increases expression	ISO	19	11,261,631	11,262,647	RGD:6480464	CTD
G	Mt2A	metallothionein 2A		increases expression	ISO	19	11,267,811	11,268,585	RGD:6480464	CTD
G	Myc	myelocytomatosis oncogene		decreases expression	ISO	7	98,953,142	98,958,060	RGD:6480464	CTD
G	Nppa	natriuretic peptide A		increases expression	ISO	5	165,074,518	165,075,827	RGD:6480464	CTD
G	Nr4a1	nuclear receptor subfamily 4, group A, member 1		multiple interactions	ISO	7	140,012,807	140,020,590	RGD:6480464	CTD
G	Oat	ornithine aminotransferase		multiple interactions	EXP	1	192,026,623	192,046,404	RGD:6480464	CTD
G	Pklr	pyruvate kinase, liver and RBC		increases expression	EXP	2	181,214,853	181,223,505	RGD:6480464	CTD
G	Pomc	proopiomelanocortin		increases secretion	ISO	6	26,931,969	26,937,789	RGD:6480464	CTD
G	Pparg	peroxisome proliferator-activated receptor gamma		multiple interactions	EXP	4	151,492,220	151,617,331	RGD:6480464	CTD
G	Pparg	peroxisome proliferator-activated receptor gamma		decreases expression	EXP	4	151,492,220	151,617,331	RGD:6480464	CTD
G	Si	sucrase-isomaltase (alpha-glucosidase)		increases expression	EXP	2	163,520,975	163,601,280	RGD:6480464	CTD
G	Slc2a2	solute carrier family 2 (facilitated glucose transporter), member 2		increases expression	EXP	2	116,036,501	116,065,834	RGD:6480464	CTD
G	Slc5a1	solute carrier family 5 (sodium/glucose cotransporter), member 1		increases expression	EXP	14	83,311,232	83,370,657	RGD:6480464	CTD
G	Tp53	tumor protein p53		increases activity	ISO	10	56,399,721	56,411,150	RGD:6480464	CTD
gonadorelin
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Esr1	estrogen receptor 1		multiple interactions	ISO	1	35,523,680	35,759,891	RGD:6480464	CTD
G	Ube2d2	ubiquitin-conjugating enzyme E2D 2		increases expression	ISO	18	28,426,503	28,434,785	RGD:6480464	CTD
Ile(5)-angiotensin II
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Agtr2	angiotensin II receptor, type 2		increases expression	EXP				RGD:6480464	CTD
G	Ednrb	endothelin receptor type B		increases expression	EXP	15	87,893,141	87,898,700	RGD:6480464	CTD
iopromide
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Edn1	endothelin 1		increases expression	EXP	17	28,303,886	28,309,775	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		decreases expression	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
lisinopril dihydrate
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Ache	acetylcholinesterase		multiple interactions	ISO				RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		decreases expression	ISO	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		increases expression	EXP	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		affects response to substance	ISO	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		decreases expression	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Cd2ap	CD2-associated protein		multiple interactions	EXP	9	13,827,015	13,888,338	RGD:6480464	CTD
G	Edn1	endothelin 1		decreases secretion	ISO	17	28,303,886	28,309,775	RGD:6480464	CTD
G	Gh1	growth hormone 1		multiple interactions	EXP	10	95,692,240	95,694,117	RGD:6480464	CTD
G	Havcr1	hepatitis A virus cellular receptor 1		multiple interactions	EXP	10	31,834,519	31,858,019	RGD:6480464	CTD
G	Hpse	heparanase		multiple interactions	EXP	14	10,144,322	10,185,115	RGD:6480464	CTD
G	Igfbp1	insulin-like growth factor binding protein 1		increases expression	ISO	14	87,950,222	87,955,289	RGD:6480464	CTD
G	Mmp2	matrix metallopeptidase 2		multiple interactions	EXP	19	15,246,036	15,275,061	RGD:6480464	CTD
G	Mpo	myeloperoxidase		multiple interactions	ISO	10	76,085,872	76,097,012	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		multiple interactions	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nphs1	nephrosis 1, congenital, Finnish type (nephrin)		multiple interactions	EXP	1	85,414,492	85,444,233	RGD:6480464	CTD
G	Nphs1	nephrosis 1, congenital, Finnish type (nephrin)		multiple interactions	EXP	1	85,414,492	85,444,233	RGD:6480464	CTD
G	Nphs2	nephrosis 2, idiopathic, steroid-resistant		multiple interactions	EXP	13	71,296,482	71,308,868	RGD:6480464	CTD
G	Nppa	natriuretic peptide A		decreases expression	ISO	5	165,074,518	165,075,827	RGD:6480464	CTD
G	Ren	renin		increases expression	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Ren	renin		increases expression	EXP	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Timp1	TIMP metallopeptidase inhibitor 1		multiple interactions	EXP	X	12,542,496	12,547,094	RGD:6480464	CTD
G	Vegfa	vascular endothelial growth factor A		multiple interactions	EXP	9	10,520,730	10,536,071	RGD:6480464	CTD
melatonin
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Acan	aggrecan		increases expression	ISO	1	134,787,341	134,848,992	RGD:6480464	CTD
G	Ache	acetylcholinesterase		multiple interactions	EXP				RGD:6480464	CTD
G	Ache	acetylcholinesterase		multiple interactions	EXP				RGD:6480464	CTD
G	Adipoq	adiponectin, C1Q and collagen domain containing		decreases expression	ISO	11	79,908,291	79,911,065	RGD:6480464	CTD
G	Adora2b	adenosine A2B receptor		multiple interactions	ISO	10	48,421,592	48,437,967	RGD:6480464	CTD
G	Adora2b	adenosine A2B receptor		decreases expression	ISO	10	48,421,592	48,437,967	RGD:6480464	CTD
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		decreases expression	EXP	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Akt1	v-akt murine thymoma viral oncogene homolog 1		increases phosphorylation	ISO	6	137,640,482	137,657,552	RGD:6480464	CTD
G	Akt1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	ISO	6	137,640,482	137,657,552	RGD:6480464	CTD
G	Akt1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	ISO	6	137,640,482	137,657,552	RGD:6480464	CTD
G	Alb	albumin		multiple interactions	EXP	14	19,126,935	19,142,214	RGD:6480464	CTD
G	Alpl	alkaline phosphatase, liver/bone/kidney		increases expression	ISO	5	156,501,739	156,558,727	RGD:6480464	CTD
G	Amy2a3	amylase 2a3		multiple interactions	EXP	2	209,507,212	209,518,455	RGD:6480464	CTD
G	Amy2a3	amylase 2a3		increases secretion	EXP	2	209,507,212	209,518,455	RGD:6480464	CTD
G	App	amyloid beta (A4) precursor protein		multiple interactions	ISO	11	24,457,855	24,693,851	RGD:6480464	CTD
G	App	amyloid beta (A4) precursor protein		decreases expression	ISO	11	24,457,855	24,693,851	RGD:6480464	CTD
G	App	amyloid beta (A4) precursor protein		multiple interactions	ISO	11	24,457,855	24,693,851	RGD:6480464	CTD
G	Atf4	activating transcription factor 4 (tax-responsive enhancer element B67)		multiple interactions	EXP	7	118,537,718	118,538,994	RGD:6480464	CTD
G	Atf6	activating transcription factor 6		multiple interactions	EXP	13	86,543,773	86,718,970	RGD:6480464	CTD
G	Bad	BCL2-associated agonist of cell death		multiple interactions	ISO	1	209,617,373	209,626,292	RGD:6480464	CTD
G	Bad	BCL2-associated agonist of cell death		multiple interactions	ISO	1	209,617,373	209,626,292	RGD:6480464	CTD
G	Bad	BCL2-associated agonist of cell death		increases phosphorylation	ISO	1	209,617,373	209,626,292	RGD:6480464	CTD
G	Bak1	BCL2-antagonist/killer 1		multiple interactions	ISO	20	5,255,954	5,264,593	RGD:6480464	CTD
G	Bak1	BCL2-antagonist/killer 1		multiple interactions	EXP	20	5,255,954	5,264,593	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		increases expression	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		multiple interactions	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		multiple interactions	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		increases expression	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		multiple interactions	EXP	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		multiple interactions	EXP	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		multiple interactions	EXP	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		decreases expression	EXP	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		increases expression	EXP	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		multiple interactions	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		multiple interactions	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		multiple interactions	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		multiple interactions	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		decreases expression	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		multiple interactions	EXP	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		multiple interactions	ISO	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bax	Bcl2-associated X protein		multiple interactions	EXP	1	95,933,023	95,938,176	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		multiple interactions	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		multiple interactions	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		affects localization	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		multiple interactions	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		increases expression	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		multiple interactions	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		increases expression	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		multiple interactions	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		decreases expression	ISO	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		multiple interactions	EXP	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		multiple interactions	EXP	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		multiple interactions	EXP	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		multiple interactions	EXP	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		multiple interactions	EXP	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		multiple interactions	EXP	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		decreases expression	EXP	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		multiple interactions	EXP	13	12,730,736	12,905,108	RGD:6480464	CTD
G	Bcl2l1	Bcl2-like 1		multiple interactions	EXP	3	143,129,087	143,180,199	RGD:6480464	CTD
G	Bcl2l1	Bcl2-like 1		multiple interactions	ISO	3	143,129,087	143,180,199	RGD:6480464	CTD
G	Bglap	bone gamma-carboxyglutamate (gla) protein		increases expression	ISO	2	180,482,313	180,483,290	RGD:6480464	CTD
G	Bid	BH3 interacting domain death agonist		multiple interactions	ISO	4	157,296,383	157,318,481	RGD:6480464	CTD
G	Bid	BH3 interacting domain death agonist		increases expression	ISO	4	157,296,383	157,318,481	RGD:6480464	CTD
G	Casp12	caspase 12		multiple interactions	EXP	8	2,082,933	2,110,511	RGD:6480464	CTD
G	Casp12	caspase 12		multiple interactions	EXP	8	2,082,933	2,110,511	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases activity	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		decreases activity	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		decreases expression	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases activity	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		increases activity	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		decreases activity	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	EXP	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp8	caspase 8		multiple interactions	ISO	9	57,389,353	57,437,803	RGD:6480464	CTD
G	Casp8	caspase 8		increases activity	ISO	9	57,389,353	57,437,803	RGD:6480464	CTD
G	Casp9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	ISO	5	160,704,234	160,721,796	RGD:6480464	CTD
G	Casp9	caspase 9, apoptosis-related cysteine peptidase		increases activity	ISO	5	160,704,234	160,721,796	RGD:6480464	CTD
G	Casp9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	ISO	5	160,704,234	160,721,796	RGD:6480464	CTD
G	Casp9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	5	160,704,234	160,721,796	RGD:6480464	CTD
G	Casp9	caspase 9, apoptosis-related cysteine peptidase		increases activity	ISO	5	160,704,234	160,721,796	RGD:6480464	CTD
G	Casp9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	ISO	5	160,704,234	160,721,796	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	ISO	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	ISO	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		decreases activity	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		increases expression	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	ISO	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	ISO	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		increases expression	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cck	cholecystokinin		increases secretion	EXP	8	126,492,636	126,499,220	RGD:6480464	CTD
G	Ccl2	chemokine (C-C motif) ligand 2		multiple interactions	ISO	10	70,256,263	70,258,061	RGD:6480464	CTD
G	Ccl5	chemokine (C-C motif) ligand 5		multiple interactions	ISO	10	71,605,791	71,610,330	RGD:6480464	CTD
G	Ccl9	chemokine (C-C motif) ligand 9		multiple interactions	ISO	10	71,645,931	71,650,814	RGD:6480464	CTD
G	Ccnb1	cyclin B1		decreases expression	ISO	2	31,574,600	31,581,784	RGD:6480464	CTD
G	Ccnd1	cyclin D1		decreases expression	ISO	1	205,357,235	205,366,757	RGD:6480464	CTD
G	Cd36	CD36 molecule (thrombospondin receptor)		multiple interactions	ISO	4	13,471,878	13,525,620	RGD:6480464	CTD
G	Cdk1	cyclin-dependent kinase 1		decreases expression	ISO	20	20,018,044	20,044,030	RGD:6480464	CTD
G	Cdk4	cyclin-dependent kinase 4		decreases expression	ISO				RGD:6480464	CTD
G	Cdkn1a	cyclin-dependent kinase inhibitor 1A		increases expression	ISO	20	7,376,325	7,386,778	RGD:6480464	CTD
G	Cish	cytokine inducible SH2-containing protein		multiple interactions	ISO	8	112,541,034	112,545,982	RGD:6480464	CTD
G	Cish	cytokine inducible SH2-containing protein		decreases expression	ISO	8	112,541,034	112,545,982	RGD:6480464	CTD
G	Ckb	creatine kinase, brain		multiple interactions	EXP	6	136,452,215	136,455,122	RGD:6480464	CTD
G	Clec4a3	C-type lectin domain family 4, member A3		multiple interactions	ISO	4	159,464,410	159,474,023	RGD:6480464	CTD
G	Clec4a3	C-type lectin domain family 4, member A3		increases expression	ISO	4	159,464,410	159,474,023	RGD:6480464	CTD
G	Colec12	collectin sub-family member 12		multiple interactions	ISO	18	996,297	1,188,288	RGD:6480464	CTD
G	Cry2	cryptochrome 2 (photolyase-like)		affects expression	EXP	3	76,802,782	76,830,902	RGD:6480464	CTD
G	Ctsb	cathepsin B		multiple interactions	ISO	15	42,402,829	42,423,701	RGD:6480464	CTD
G	Ctsd	cathepsin D		multiple interactions	ISO	1	202,619,669	202,631,545	RGD:6480464	CTD
G	Cxcl10	chemokine (C-X-C motif) ligand 10		multiple interactions	ISO	14	17,265,986	17,268,183	RGD:6480464	CTD
G	Cxcl10	chemokine (C-X-C motif) ligand 10		decreases expression	ISO	14	17,265,986	17,268,183	RGD:6480464	CTD
G	Cyp19a1	cytochrome P450, family 19, subfamily a, polypeptide 1		decreases expression	ISO				RGD:6480464	CTD
G	Cyp19a1	cytochrome P450, family 19, subfamily a, polypeptide 1		decreases activity	EXP				RGD:6480464	CTD
G	Cyp1a1	cytochrome P450, family 1, subfamily a, polypeptide 1		multiple interactions	EXP	8	61,462,207	61,468,237	RGD:6480464	CTD
G	Cyp1a1	cytochrome P450, family 1, subfamily a, polypeptide 1		increases hydroxylation	ISO	8	61,462,207	61,468,237	RGD:6480464	CTD
G	Cyp1a1	cytochrome P450, family 1, subfamily a, polypeptide 1		decreases activity	ISO	8	61,462,207	61,468,237	RGD:6480464	CTD
G	Cyp1a2	cytochrome P450, family 1, subfamily a, polypeptide 2		decreases methylation	ISO	8	61,439,062	61,447,861	RGD:6480464	CTD
G	Cyp1a2	cytochrome P450, family 1, subfamily a, polypeptide 2		affects metabolic processing	ISO	8	61,439,062	61,447,861	RGD:6480464	CTD
G	Cyp1a2	cytochrome P450, family 1, subfamily a, polypeptide 2		increases hydroxylation	ISO	8	61,439,062	61,447,861	RGD:6480464	CTD
G	Cyp1a2	cytochrome P450, family 1, subfamily a, polypeptide 2		multiple interactions	ISO	8	61,439,062	61,447,861	RGD:6480464	CTD
G	Cyp1a2	cytochrome P450, family 1, subfamily a, polypeptide 2		increases metabolic processing	ISO	8	61,439,062	61,447,861	RGD:6480464	CTD
G	Cyp1a2	cytochrome P450, family 1, subfamily a, polypeptide 2		decreases activity	ISO	8	61,439,062	61,447,861	RGD:6480464	CTD
G	Cyp1a2	cytochrome P450, family 1, subfamily a, polypeptide 2		multiple interactions	EXP	8	61,439,062	61,447,861	RGD:6480464	CTD
G	Cyp1a2	cytochrome P450, family 1, subfamily a, polypeptide 2		affects metabolic processing	ISO	8	61,439,062	61,447,861	RGD:6480464	CTD
G	Cyp1b1	cytochrome P450, family 1, subfamily b, polypeptide 1		multiple interactions	ISO	6	2,548,224	2,553,767	RGD:6480464	CTD
G	Cyp1b1	cytochrome P450, family 1, subfamily b, polypeptide 1		increases hydroxylation	ISO	6	2,548,224	2,553,767	RGD:6480464	CTD
G	Cyp1b1	cytochrome P450, family 1, subfamily b, polypeptide 1		decreases activity	ISO	6	2,548,224	2,553,767	RGD:6480464	CTD
G	Cyp2b2	cytochrome P450, family 2, subfamily b, polypeptide 2		multiple interactions	EXP	1	81,345,425	81,359,415	RGD:6480464	CTD
G	Cyp2e1	cytochrome P450, family 2, subfamily e, polypeptide 1		multiple interactions	EXP	1	200,918,521	200,928,919	RGD:6480464	CTD
G	Cyp2e1	cytochrome P450, family 2, subfamily e, polypeptide 1		multiple interactions	ISO	1	200,918,521	200,928,919	RGD:6480464	CTD
G	Ddit3	DNA-damage inducible transcript 3		multiple interactions	EXP	7	67,247,749	67,252,571	RGD:6480464	CTD
G	Drd2	dopamine receptor D2		multiple interactions	EXP	8	52,641,160	52,707,749	RGD:6480464	CTD
G	Eif4ebp1	eukaryotic translation initiation factor 4E binding protein 1		multiple interactions	ISO	16	69,110,522	69,123,895	RGD:6480464	CTD
G	Ern1	endoplasmic reticulum to nucleus signaling 1		multiple interactions	EXP	10	95,794,488	95,855,895	RGD:6480464	CTD
G	Esr1	estrogen receptor 1		multiple interactions	ISO	1	35,523,680	35,759,891	RGD:6480464	CTD
G	Esr1	estrogen receptor 1		multiple interactions	ISO	1	35,523,680	35,759,891	RGD:6480464	CTD
G	Esr1	estrogen receptor 1		decreases expression	ISO	1	35,523,680	35,759,891	RGD:6480464	CTD
G	Esr1	estrogen receptor 1		multiple interactions	EXP	1	35,523,680	35,759,891	RGD:6480464	CTD
G	Esr1	estrogen receptor 1		decreases expression	EXP	1	35,523,680	35,759,891	RGD:6480464	CTD
G	Fabp4	fatty acid binding protein 4, adipocyte		decreases expression	ISO	2	93,536,133	93,540,734	RGD:6480464	CTD
G	Fas	Fas (TNF receptor superfamily, member 6)		multiple interactions	EXP	1	238,259,443	238,274,745	RGD:6480464	CTD
G	Faslg	Fas ligand (TNF superfamily, member 6)		multiple interactions	EXP	13	77,472,950	77,480,210	RGD:6480464	CTD
G	Fasn	fatty acid synthase		multiple interactions	ISO				RGD:6480464	CTD
G	Fcgr2b	Fc fragment of IgG, low affinity IIb, receptor (CD32)		multiple interactions	ISO	13	86,809,011	86,823,599	RGD:6480464	CTD
G	Fcgr2b	Fc fragment of IgG, low affinity IIb, receptor (CD32)		decreases expression	ISO	13	86,809,011	86,823,599	RGD:6480464	CTD
G	Fgf9	fibroblast growth factor 9		multiple interactions	EXP	15	37,115,068	37,155,652	RGD:6480464	CTD
G	Fn1	fibronectin 1		multiple interactions	EXP	9	70,702,181	70,771,155	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		multiple interactions	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	G6pd	glucose-6-phosphate dehydrogenase		increases activity	EXP	X	160,186,450	160,192,316	RGD:6480464	CTD
G	Gap43	growth associated protein 43		multiple interactions	EXP	11	59,989,085	60,083,971	RGD:6480464	CTD
G	Gast	gastrin		multiple interactions	EXP	10	89,273,628	89,276,192	RGD:6480464	CTD
G	Gast	gastrin		increases expression	EXP	10	89,273,628	89,276,192	RGD:6480464	CTD
G	Gast	gastrin		increases expression	EXP	10	89,273,628	89,276,192	RGD:6480464	CTD
G	Gfap	glial fibrillary acidic protein		multiple interactions	EXP	10	92,059,881	92,068,555	RGD:6480464	CTD
G	Ggt1	gamma-glutamyltransferase 1		multiple interactions	EXP				RGD:6480464	CTD
G	Gpt	glutamic-pyruvate transaminase (alanine aminotransferase)		multiple interactions	EXP	7	114,746,054	114,748,903	RGD:6480464	CTD
G	Gpx1	glutathione peroxidase 1		increases expression	EXP				RGD:6480464	CTD
G	Gpx1	glutathione peroxidase 1		multiple interactions	EXP				RGD:6480464	CTD
G	Gpx2	glutathione peroxidase 2		multiple interactions	EXP	6	99,372,418	99,376,230	RGD:6480464	CTD
G	Gsk3b	glycogen synthase kinase 3 beta		multiple interactions	ISO	11	64,284,731	64,428,698	RGD:6480464	CTD
G	Gsr	glutathione reductase		multiple interactions	EXP	16	62,255,562	62,298,458	RGD:6480464	CTD
G	Gsr	glutathione reductase		multiple interactions	EXP	16	62,255,562	62,298,458	RGD:6480464	CTD
G	Gsr	glutathione reductase		increases activity	EXP	16	62,255,562	62,298,458	RGD:6480464	CTD
G	Gsr	glutathione reductase		increases activity	EXP	16	62,255,562	62,298,458	RGD:6480464	CTD
G	Gsr	glutathione reductase		increases activity	EXP	16	62,255,562	62,298,458	RGD:6480464	CTD
G	Gsr	glutathione reductase		multiple interactions	EXP	16	62,255,562	62,298,458	RGD:6480464	CTD
G	Gsr	glutathione reductase		decreases expression	EXP	16	62,255,562	62,298,458	RGD:6480464	CTD
G	Gsr	glutathione reductase		increases activity	EXP	16	62,255,562	62,298,458	RGD:6480464	CTD
G	Gsr	glutathione reductase		multiple interactions	ISO	16	62,255,562	62,298,458	RGD:6480464	CTD
G	Gsr	glutathione reductase		multiple interactions	ISO	16	62,255,562	62,298,458	RGD:6480464	CTD
G	Gsr	glutathione reductase		decreases expression	ISO	16	62,255,562	62,298,458	RGD:6480464	CTD
G	Gsr	glutathione reductase		multiple interactions	EXP	16	62,255,562	62,298,458	RGD:6480464	CTD
G	Gsta4	glutathione S-transferase alpha 4		multiple interactions	ISO	8	83,165,139	83,183,055	RGD:6480464	CTD
G	Gsta5	glutathione S-transferase alpha 5		multiple interactions	EXP	8	83,202,554	83,211,997	RGD:6480464	CTD
G	Gstm1	glutathione S-transferase mu 1		multiple interactions	EXP	2	203,575,444	203,580,821	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		increases expression	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		multiple interactions	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		multiple interactions	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		multiple interactions	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		multiple interactions	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		multiple interactions	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		multiple interactions	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		decreases expression	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		multiple interactions	ISO	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox2	heme oxygenase (decycling) 2		decreases expression	EXP	10	10,914,157	10,929,448	RGD:6480464	CTD
G	Hmox2	heme oxygenase (decycling) 2		multiple interactions	EXP	10	10,914,157	10,929,448	RGD:6480464	CTD
G	Hspa5	heat shock protein 5		multiple interactions	EXP	3	13,783,825	13,788,022	RGD:6480464	CTD
G	Hspa9	heat shock protein 9		multiple interactions	EXP	18	27,419,614	27,437,031	RGD:6480464	CTD
G	Ifng	interferon gamma		multiple interactions	ISO	7	57,621,756	57,625,792	RGD:6480464	CTD
G	Il10	interleukin 10		multiple interactions	ISO	13	43,953,900	43,957,766	RGD:6480464	CTD
G	Il1a	interleukin 1 alpha		multiple interactions	ISO	3	116,913,612	116,924,114	RGD:6480464	CTD
G	Il1a	interleukin 1 alpha		decreases expression	ISO	3	116,913,612	116,924,114	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		multiple interactions	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		multiple interactions	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		decreases expression	ISO	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		multiple interactions	EXP	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		multiple interactions	EXP	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		multiple interactions	EXP	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il2	interleukin 2		increases activity	ISO	2	123,655,005	123,659,709	RGD:6480464	CTD
G	Il2	interleukin 2		multiple interactions	ISO	2	123,655,005	123,659,709	RGD:6480464	CTD
G	Il6	interleukin 6		multiple interactions	EXP	4	456,799	461,376	RGD:6480464	CTD
G	Il6	interleukin 6		multiple interactions	ISO	4	456,799	461,376	RGD:6480464	CTD
G	Il6	interleukin 6		multiple interactions	ISO	4	456,799	461,376	RGD:6480464	CTD
G	Ins1	insulin 1		multiple interactions	EXP	1	258,001,134	258,001,688	RGD:6480464	CTD
G	Insr	insulin receptor		multiple interactions	EXP	12	2,934,967	3,087,691	RGD:6480464	CTD
G	Lep	leptin		decreases expression	ISO	4	55,943,837	55,945,938	RGD:6480464	CTD
G	Lep	leptin		decreases expression	EXP	4	55,943,837	55,945,938	RGD:6480464	CTD
G	Lhb	luteinizing hormone beta		multiple interactions	EXP	1	95,892,999	95,893,988	RGD:6480464	CTD
G	Lpl	lipoprotein lipase		decreases expression	ISO	16	22,533,105	22,556,905	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	EXP	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk10	mitogen activated protein kinase 10		increases expression	ISO	14	7,719,595	8,010,694	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	EXP	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk8	mitogen-activated protein kinase 8		increases expression	ISO	16	8,925,133	9,004,897	RGD:6480464	CTD
G	Mapk9	mitogen-activated protein kinase 9		increases expression	ISO	10	35,353,486	35,384,319	RGD:6480464	CTD
G	Mapt	microtubule-associated protein tau		multiple interactions	ISO	10	93,411,098	93,508,762	RGD:6480464	CTD
G	Mapt	microtubule-associated protein tau		multiple interactions	ISO	10	93,411,098	93,508,762	RGD:6480464	CTD
G	Mcl1	myeloid cell leukemia sequence 1		multiple interactions	ISO				RGD:6480464	CTD
G	Me1	malic enzyme 1, NADP(+)-dependent, cytosolic		multiple interactions	EXP	8	91,839,845	91,955,917	RGD:6480464	CTD
G	Mki67	antigen identified by monoclonal antibody Ki-67		multiple interactions	EXP	1	195,310,027	195,336,224	RGD:6480464	CTD
G	Mki67	antigen identified by monoclonal antibody Ki-67		decreases expression	ISO	1	195,310,027	195,336,224	RGD:6480464	CTD
G	Mmp14	matrix metallopeptidase 14 (membrane-inserted)		multiple interactions	EXP	15	32,493,852	32,503,077	RGD:6480464	CTD
G	Mmp2	matrix metallopeptidase 2		multiple interactions	EXP	19	15,246,036	15,275,061	RGD:6480464	CTD
G	Mmp2	matrix metallopeptidase 2		multiple interactions	EXP	19	15,246,036	15,275,061	RGD:6480464	CTD
G	Mmp9	matrix metallopeptidase 9		multiple interactions	EXP	3	155,985,473	155,993,433	RGD:6480464	CTD
G	Mtnr1a	melatonin receptor 1A		affects binding	ISO	16	50,439,407	50,458,585	RGD:6480464	CTD
G	Mtnr1a	melatonin receptor 1A		affects binding	ISO	16	50,439,407	50,458,585	RGD:6480464	CTD
G	Mtnr1a	melatonin receptor 1A		affects binding	ISO	16	50,439,407	50,458,585	RGD:6480464	CTD
G	Mtnr1a	melatonin receptor 1A		affects binding	ISO	16	50,439,407	50,458,585	RGD:6480464	CTD
G	Mtnr1b	melatonin receptor 1B		affects binding	ISO	8	12,625,154	12,639,670	RGD:6480464	CTD
G	Mtnr1b	melatonin receptor 1B		multiple interactions	ISO	8	12,625,154	12,639,670	RGD:6480464	CTD
G	Mtnr1b	melatonin receptor 1B		affects binding	ISO	8	12,625,154	12,639,670	RGD:6480464	CTD
G	Mtnr1b	melatonin receptor 1B		affects binding	ISO	8	12,625,154	12,639,670	RGD:6480464	CTD
G	Mtnr1b	melatonin receptor 1B		affects binding	ISO	8	12,625,154	12,639,670	RGD:6480464	CTD
G	Mtnr1b	melatonin receptor 1B		affects binding	ISO	8	12,625,154	12,639,670	RGD:6480464	CTD
G	Mtor	mechanistic target of rapamycin (serine/threonine kinase)		multiple interactions	ISO	5	165,531,402	165,640,899	RGD:6480464	CTD
G	Mtor	mechanistic target of rapamycin (serine/threonine kinase)		increases activity	ISO	5	165,531,402	165,640,899	RGD:6480464	CTD
G	Nefh	neurofilament, heavy polypeptide		decreases phosphorylation	ISO	14	85,594,789	85,604,774	RGD:6480464	CTD
G	Nes	nestin		decreases expression	ISO	2	180,051,907	180,060,947	RGD:6480464	CTD
G	Nes	nestin		multiple interactions	EXP	2	180,051,907	180,060,947	RGD:6480464	CTD
G	Nes	nestin		decreases expression	EXP	2	180,051,907	180,060,947	RGD:6480464	CTD
G	Nfe2l2	nuclear factor, erythroid derived 2, like 2		multiple interactions	EXP	3	58,366,693	58,394,116	RGD:6480464	CTD
G	Nfe2l2	nuclear factor, erythroid derived 2, like 2		increases expression	EXP	3	58,366,693	58,394,116	RGD:6480464	CTD
G	Nfkb1	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1		multiple interactions	EXP	2	233,091,013	233,187,501	RGD:6480464	CTD
G	Nfkb1	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1		multiple interactions	ISO	2	233,091,013	233,187,501	RGD:6480464	CTD
G	Nos1	nitric oxide synthase 1, neuronal		multiple interactions	EXP	12	39,812,500	39,869,484	RGD:6480464	CTD
G	Nos1	nitric oxide synthase 1, neuronal		decreases expression	EXP	12	39,812,500	39,869,484	RGD:6480464	CTD
G	Nos1	nitric oxide synthase 1, neuronal		decreases expression	EXP	12	39,812,500	39,869,484	RGD:6480464	CTD
G	Nos1	nitric oxide synthase 1, neuronal		decreases expression	EXP	12	39,812,500	39,869,484	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		multiple interactions	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		multiple interactions	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		increases expression	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		decreases expression	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		multiple interactions	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		multiple interactions	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		multiple interactions	ISO	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Nqo1	NAD(P)H dehydrogenase, quinone 1		multiple interactions	EXP	19	37,251,147	37,266,040	RGD:6480464	CTD
G	Nqo1	NAD(P)H dehydrogenase, quinone 1		multiple interactions	EXP	19	37,251,147	37,266,040	RGD:6480464	CTD
G	Nqo1	NAD(P)H dehydrogenase, quinone 1		increases expression	EXP	19	37,251,147	37,266,040	RGD:6480464	CTD
G	Nqo2	NAD(P)H dehydrogenase, quinone 2		multiple interactions	ISO	17	37,255,630	37,283,753	RGD:6480464	CTD
G	Nr1h3	nuclear receptor subfamily 1, group H, member 3		multiple interactions	ISO	3	75,542,211	75,550,793	RGD:6480464	CTD
G	Nr1i2	nuclear receptor subfamily 1, group I, member 2		multiple interactions	ISO	11	64,239,918	64,276,702	RGD:6480464	CTD
G	Nr3c1	nuclear receptor subfamily 3, group C, member 1		multiple interactions	ISO	18	32,371,496	32,459,145	RGD:6480464	CTD
G	Nr3c1	nuclear receptor subfamily 3, group C, member 1		multiple interactions	ISO	18	32,371,496	32,459,145	RGD:6480464	CTD
G	Nr3c1	nuclear receptor subfamily 3, group C, member 1		affects localization	ISO	18	32,371,496	32,459,145	RGD:6480464	CTD
G	Nr3c1	nuclear receptor subfamily 3, group C, member 1		multiple interactions	EXP	18	32,371,496	32,459,145	RGD:6480464	CTD
G	Pawr	PRKC, apoptosis, WT1, regulator		decreases expression	EXP	7	47,040,162	47,119,613	RGD:6480464	CTD
G	Pcna	proliferating cell nuclear antigen		multiple interactions	EXP	3	120,008,715	120,012,589	RGD:6480464	CTD
G	Pcna	proliferating cell nuclear antigen		decreases expression	ISO	3	120,008,715	120,012,589	RGD:6480464	CTD
G	Per1	period circadian clock 1		multiple interactions	EXP	10	55,859,851	55,868,747	RGD:6480464	CTD
G	Per1	period circadian clock 1		multiple interactions	EXP	10	55,859,851	55,868,747	RGD:6480464	CTD
G	Per2	period circadian clock 2		multiple interactions	EXP	9	90,645,342	90,687,509	RGD:6480464	CTD
G	Per2	period circadian clock 2		affects expression	EXP	9	90,645,342	90,687,509	RGD:6480464	CTD
G	Pf4	platelet factor 4		multiple interactions	ISO	14	18,812,550	18,813,259	RGD:6480464	CTD
G	Pgr	progesterone receptor		multiple interactions	ISO	8	5,784,717	5,845,901	RGD:6480464	CTD
G	Pomc	proopiomelanocortin		multiple interactions	EXP	6	26,931,969	26,937,789	RGD:6480464	CTD
G	Pparg	peroxisome proliferator-activated receptor gamma		decreases expression	ISO	4	151,492,220	151,617,331	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	ISO	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Rara	retinoic acid receptor, alpha		multiple interactions	ISO	10	87,740,479	87,753,265	RGD:6480464	CTD
G	Rara	retinoic acid receptor, alpha		multiple interactions	ISO	10	87,740,479	87,753,265	RGD:6480464	CTD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)		multiple interactions	ISO	1	208,262,669	208,273,148	RGD:6480464	CTD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)		multiple interactions	EXP	1	208,262,669	208,273,148	RGD:6480464	CTD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)		multiple interactions	EXP	1	208,262,669	208,273,148	RGD:6480464	CTD
G	Rora	RAR-related orphan receptor A		affects binding	ISO	8	73,052,282	73,817,764	RGD:6480464	CTD
G	Rora	RAR-related orphan receptor A		affects binding	ISO	8	73,052,282	73,817,764	RGD:6480464	CTD
G	Runx2	runt-related transcription factor 2		increases expression	ISO	9	11,869,234	12,025,219	RGD:6480464	CTD
G	S100g	S100 calcium binding protein G		increases expression	EXP	X	52,446,817	52,449,342	RGD:6480464	CTD
G	S100g	S100 calcium binding protein G		multiple interactions	EXP	X	52,446,817	52,449,342	RGD:6480464	CTD
G	Sirt1	sirtuin 1		decreases expression	ISO	20	25,675,302	25,686,494	RGD:6480464	CTD
G	Sirt1	sirtuin 1		decreases expression	ISO	20	25,675,302	25,686,494	RGD:6480464	CTD
G	Sirt1	sirtuin 1		decreases expression	ISO	20	25,675,302	25,686,494	RGD:6480464	CTD
G	Slc18a2	solute carrier family 18 (vesicular monoamine), member 2		multiple interactions	ISO	1	265,789,917	265,824,551	RGD:6480464	CTD
G	Slc2a4	solute carrier family 2 (facilitated glucose transporter), member 4		multiple interactions	EXP	10	56,786,705	56,792,209	RGD:6480464	CTD
G	Slc6a3	solute carrier family 6 (neurotransmitter transporter, dopamine), member 3		multiple interactions	EXP	1	30,516,568	30,557,540	RGD:6480464	CTD
G	Snca	synuclein, alpha (non A4 component of amyloid precursor)		multiple interactions	EXP	4	89,613,731	89,722,807	RGD:6480464	CTD
G	Snca	synuclein, alpha (non A4 component of amyloid precursor)		multiple interactions	EXP	4	89,613,731	89,722,807	RGD:6480464	CTD
G	Sod1	superoxide dismutase 1, soluble		multiple interactions	EXP	11	29,810,766	29,816,342	RGD:6480464	CTD
G	Sod1	superoxide dismutase 1, soluble		multiple interactions	EXP	11	29,810,766	29,816,342	RGD:6480464	CTD
G	Sod1	superoxide dismutase 1, soluble		multiple interactions	EXP	11	29,810,766	29,816,342	RGD:6480464	CTD
G	Sod1	superoxide dismutase 1, soluble		multiple interactions	EXP	11	29,810,766	29,816,342	RGD:6480464	CTD
G	Sod1	superoxide dismutase 1, soluble		increases expression	EXP	11	29,810,766	29,816,342	RGD:6480464	CTD
G	Sod1	superoxide dismutase 1, soluble		multiple interactions	ISO	11	29,810,766	29,816,342	RGD:6480464	CTD
G	Sod1	superoxide dismutase 1, soluble		increases expression	EXP	11	29,810,766	29,816,342	RGD:6480464	CTD
G	Sod1	superoxide dismutase 1, soluble		multiple interactions	EXP	11	29,810,766	29,816,342	RGD:6480464	CTD
G	Sod2	superoxide dismutase 2, mitochondrial		increases expression	EXP	1	41,862,997	41,870,327	RGD:6480464	CTD
G	Sod2	superoxide dismutase 2, mitochondrial		multiple interactions	EXP	1	41,862,997	41,870,327	RGD:6480464	CTD
G	Sod2	superoxide dismutase 2, mitochondrial		multiple interactions	EXP	1	41,862,997	41,870,327	RGD:6480464	CTD
G	Sod2	superoxide dismutase 2, mitochondrial		increases expression	EXP	1	41,862,997	41,870,327	RGD:6480464	CTD
G	Sod2	superoxide dismutase 2, mitochondrial		multiple interactions	ISO	1	41,862,997	41,870,327	RGD:6480464	CTD
G	Sod2	superoxide dismutase 2, mitochondrial		increases expression	EXP	1	41,862,997	41,870,327	RGD:6480464	CTD
G	Srebf1	sterol regulatory element binding transcription factor 1		multiple interactions	ISO	10	46,461,684	46,483,646	RGD:6480464	CTD
G	Stat1	signal transducer and activator of transcription 1		multiple interactions	ISO	9	46,455,635	46,497,560	RGD:6480464	CTD
G	Stat1	signal transducer and activator of transcription 1		multiple interactions	ISO	9	46,455,635	46,497,560	RGD:6480464	CTD
G	Stat3	signal transducer and activator of transcription 3 (acute-phase response factor)		multiple interactions	ISO	10	89,821,078	89,872,970	RGD:6480464	CTD
G	Stat3	signal transducer and activator of transcription 3 (acute-phase response factor)		multiple interactions	EXP	10	89,821,078	89,872,970	RGD:6480464	CTD
G	Stat3	signal transducer and activator of transcription 3 (acute-phase response factor)		increases phosphorylation	ISO	10	89,821,078	89,872,970	RGD:6480464	CTD
G	Stat3	signal transducer and activator of transcription 3 (acute-phase response factor)		increases response to substance	ISO	10	89,821,078	89,872,970	RGD:6480464	CTD
G	Syp	synaptophysin		multiple interactions	EXP	X	26,890,307	26,905,319	RGD:6480464	CTD
G	Syp	synaptophysin		multiple interactions	EXP	X	26,890,307	26,905,319	RGD:6480464	CTD
G	Tdo2	tryptophan 2,3-dioxygenase		multiple interactions	EXP	2	173,594,020	173,611,833	RGD:6480464	CTD
G	Tf	transferrin		increases expression	EXP	8	108,217,774	108,244,487	RGD:6480464	CTD
G	Tf	transferrin		multiple interactions	EXP	8	108,217,774	108,244,487	RGD:6480464	CTD
G	Tfrc	transferrin receptor		decreases expression	EXP	11	69,976,258	69,998,098	RGD:6480464	CTD
G	Tfrc	transferrin receptor		decreases expression	EXP	11	69,976,258	69,998,098	RGD:6480464	CTD
G	Tgfb1	transforming growth factor, beta 1		multiple interactions	ISO	1	80,894,705	80,911,020	RGD:6480464	CTD
G	Tgfb1	transforming growth factor, beta 1		multiple interactions	EXP	1	80,894,705	80,911,020	RGD:6480464	CTD
G	Th	tyrosine hydroxylase		multiple interactions	EXP	1	203,164,253	203,171,506	RGD:6480464	CTD
G	Th	tyrosine hydroxylase		multiple interactions	EXP	1	203,164,253	203,171,506	RGD:6480464	CTD
G	Th	tyrosine hydroxylase		multiple interactions	ISO	1	203,164,253	203,171,506	RGD:6480464	CTD
G	Timp2	TIMP metallopeptidase inhibitor 2		multiple interactions	EXP	10	108,310,473	108,358,821	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnfrsf1b	tumor necrosis factor receptor superfamily, member 1b		increases response to substance	ISO	5	163,666,541	163,697,484	RGD:6480464	CTD
G	Tp53	tumor protein p53		increases expression	ISO	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Tp53	tumor protein p53		multiple interactions	EXP	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Tp53	tumor protein p53		multiple interactions	EXP	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Tp53	tumor protein p53		increases expression	ISO	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Tp53	tumor protein p53		multiple interactions	ISO	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Tshb	thyroid stimulating hormone, beta		multiple interactions	EXP	2	197,908,308	197,913,186	RGD:6480464	CTD
G	Ugt1a6	UDP glucuronosyltransferase 1 family, polypeptide A6		multiple interactions	EXP	9	87,037,154	87,098,362	RGD:6480464	CTD
G	Xbp1	X-box binding protein 1		multiple interactions	EXP	14	86,151,910	86,156,975	RGD:6480464	CTD
G	Ywhab	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide		multiple interactions	ISO	3	154,926,025	154,948,297	RGD:6480464	CTD
nitroglycerin
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Acat1	acetyl-CoA acetyltransferase 1		increases expression	EXP	8	57,044,478	57,072,970	RGD:6480464	CTD
G	Actb	actin, beta		decreases expression	EXP	12	12,047,070	12,050,040	RGD:6480464	CTD
G	Aldh1a1	aldehyde dehydrogenase 1 family, member A1		decreases expression	EXP	1	223,731,675	223,773,285	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		multiple interactions	ISO	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		affects response to substance	ISO	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		affects metabolic processing	ISO	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		multiple interactions	ISO	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		affects response to substance	ISO	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		affects response to substance	ISO	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		decreases activity	ISO	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		decreases activity	ISO	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		multiple interactions	EXP	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		multiple interactions	EXP	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		multiple interactions	EXP	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		decreases activity	EXP	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		decreases expression	EXP	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		decreases expression	EXP	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		decreases activity	EXP	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		decreases activity	EXP	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		decreases expression	EXP	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		decreases activity	EXP	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		increases response to substance	ISO	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Aldh2	aldehyde dehydrogenase 2 family (mitochondrial)		decreases activity	ISO	12	36,081,778	36,116,445	RGD:6480464	CTD
G	Alox15	arachidonate 15-lipoxygenase		decreases expression	EXP	10	57,185,939	57,194,388	RGD:6480464	CTD
G	Ap2m1	adaptor-related protein complex 2, mu 1 subunit		increases expression	EXP	11	82,585,474	82,591,832	RGD:6480464	CTD
G	Apex1	APEX nuclease (multifunctional DNA repair enzyme) 1		increases expression	EXP	15	26,904,124	26,906,224	RGD:6480464	CTD
G	Apoa1	apolipoprotein A-I		decreases expression	EXP				RGD:6480464	CTD
G	Arl2	ADP-ribosylation factor-like 2		increases expression	EXP	1	208,909,458	208,921,401	RGD:6480464	CTD
G	Atp5a1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle		decreases expression	EXP	18	74,735,267	74,743,088	RGD:6480464	CTD
G	B2m	beta-2 microglobulin		affects expression	ISO	3	108,927,919	108,932,718	RGD:6480464	CTD
G	Bckdhb	branched chain keto acid dehydrogenase E1, beta polypeptide		decreases expression	EXP	8	88,997,979	89,191,017	RGD:6480464	CTD
G	Bcl2	B-cell CLL/lymphoma 2		decreases expression	EXP	13	12,730,736	12,905,108	RGD:6480464	CTD
G	C3	complement component 3		increases expression	ISO				RGD:6480464	CTD
G	Calca	calcitonin-related polypeptide alpha		multiple interactions	EXP	1	172,686,168	172,691,061	RGD:6480464	CTD
G	Calca	calcitonin-related polypeptide alpha		affects expression	ISO	1	172,686,168	172,691,061	RGD:6480464	CTD
G	Calca	calcitonin-related polypeptide alpha		multiple interactions	EXP	1	172,686,168	172,691,061	RGD:6480464	CTD
G	Calca	calcitonin-related polypeptide alpha		multiple interactions	EXP	1	172,686,168	172,691,061	RGD:6480464	CTD
G	Calca	calcitonin-related polypeptide alpha		increases expression	EXP	1	172,686,168	172,691,061	RGD:6480464	CTD
G	Calca	calcitonin-related polypeptide alpha		increases expression	EXP	1	172,686,168	172,691,061	RGD:6480464	CTD
G	Calca	calcitonin-related polypeptide alpha		increases expression	EXP	1	172,686,168	172,691,061	RGD:6480464	CTD
G	Calm2	calmodulin 2		increases expression	EXP	6	64,161,641	64,162,751	RGD:6480464	CTD
G	Capn2	calpain 2, (m/II) large subunit		decreases expression	EXP	13	98,473,367	98,524,463	RGD:6480464	CTD
G	Casp1	caspase 1		multiple interactions	ISO	8	2,027,976	2,036,872	RGD:6480464	CTD
G	Casp3	caspase 3		decreases expression	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Casp3	caspase 3		multiple interactions	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Cat	catalase		multiple interactions	EXP	3	88,654,077	88,686,212	RGD:6480464	CTD
G	Cd3d	CD3 molecule, delta		increases expression	EXP	8	47,932,151	47,936,744	RGD:6480464	CTD
G	Cd5	Cd5 molecule		decreases expression	EXP	1	213,213,327	213,234,277	RGD:6480464	CTD
G	Cd53	Cd53 molecule		decreases expression	EXP	2	202,186,125	202,234,570	RGD:6480464	CTD
G	Cdc37	cell division cycle 37		increases expression	EXP	8	20,164,150	20,176,763	RGD:6480464	CTD
G	Cdkn1b	cyclin-dependent kinase inhibitor 1B		increases expression	EXP	4	171,841,705	171,846,506	RGD:6480464	CTD
G	Celf2	CUGBP, Elav-like family member 2		increases expression	EXP	17	82,708,354	83,025,139	RGD:6480464	CTD
G	Ckb	creatine kinase, brain		decreases expression	EXP	6	136,452,215	136,455,122	RGD:6480464	CTD
G	Clu	clusterin		decreases expression	EXP	15	45,365,779	45,405,314	RGD:6480464	CTD
G	Cnr1	cannabinoid receptor 1 (brain)		multiple interactions	EXP	5	50,427,173	50,445,471	RGD:6480464	CTD
G	Cp	ceruloplasmin (ferroxidase)		decreases expression	EXP	2	105,086,278	105,135,367	RGD:6480464	CTD
G	Crip2	cysteine-rich protein 2		decreases expression	EXP	6	138,147,462	138,152,407	RGD:6480464	CTD
G	Ctnnb1	catenin (cadherin associated protein), beta 1		multiple interactions	ISO	8	125,978,161	125,987,670	RGD:6480464	CTD
G	Ctnnb1	catenin (cadherin associated protein), beta 1		decreases localization	ISO	8	125,978,161	125,987,670	RGD:6480464	CTD
G	Ctsd	cathepsin D		decreases expression	EXP	1	202,619,669	202,631,545	RGD:6480464	CTD
G	Cybb	cytochrome b-245, beta polypeptide		multiple interactions	ISO	X	25,514,572	25,547,181	RGD:6480464	CTD
G	Cybb	cytochrome b-245, beta polypeptide		decreases response to substance	ISO	X	25,514,572	25,547,181	RGD:6480464	CTD
G	Cybb	cytochrome b-245, beta polypeptide		multiple interactions	ISO	X	25,514,572	25,547,181	RGD:6480464	CTD
G	Cybb	cytochrome b-245, beta polypeptide		increases expression	ISO	X	25,514,572	25,547,181	RGD:6480464	CTD
G	Cybb	cytochrome b-245, beta polypeptide		decreases expression	EXP	X	25,514,572	25,547,181	RGD:6480464	CTD
G	Cyp11b2	cytochrome P450, family 11, subfamily b, polypeptide 2		decreases expression	EXP	7	113,043,365	113,049,779	RGD:6480464	CTD
G	Cyp2b15	cytochrome P450, family 2, subfamily b, polypeptide 15		decreases expression	EXP	1	81,839,930	81,852,366	RGD:6480464	CTD
G	Cyp2e1	cytochrome P450, family 2, subfamily e, polypeptide 1		increases expression	EXP	1	200,918,521	200,928,919	RGD:6480464	CTD
G	Dhcr7	7-dehydrocholesterol reductase		decreases expression	EXP	1	204,245,562	204,258,913	RGD:6480464	CTD
G	Dync1i1	dynein cytoplasmic 1 intermediate chain 1		decreases expression	EXP	4	30,496,410	30,809,622	RGD:6480464	CTD
G	Dyrk1a	dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A		decreases expression	EXP	11	34,879,733	34,970,998	RGD:6480464	CTD
G	Edn1	endothelin 1		decreases expression	ISO	17	28,303,886	28,309,775	RGD:6480464	CTD
G	Edn1	endothelin 1		multiple interactions	EXP	17	28,303,886	28,309,775	RGD:6480464	CTD
G	Edn1	endothelin 1		decreases expression	EXP	17	28,303,886	28,309,775	RGD:6480464	CTD
G	Edn1	endothelin 1		increases expression	EXP	17	28,303,886	28,309,775	RGD:6480464	CTD
G	Elane	elastase, neutrophil expressed		increases expression	ISO	7	11,329,642	11,331,490	RGD:6480464	CTD
G	Eln	elastin		increases expression	EXP	12	23,033,657	23,077,043	RGD:6480464	CTD
G	Faah	fatty acid amide hydrolase		multiple interactions	EXP	5	136,310,965	136,329,817	RGD:6480464	CTD
G	Faah	fatty acid amide hydrolase		increases activity	EXP	5	136,310,965	136,329,817	RGD:6480464	CTD
G	Fas	Fas (TNF receptor superfamily, member 6)		multiple interactions	ISO	1	238,259,443	238,274,745	RGD:6480464	CTD
G	Fgfr2	fibroblast growth factor receptor 2		increases expression	EXP	1	189,482,975	189,589,279	RGD:6480464	CTD
G	Fmo1	flavin containing monooxygenase 1		decreases expression	EXP	13	78,503,770	78,536,359	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	ISO	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		multiple interactions	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		multiple interactions	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		increases expression	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Gchfr	GTP cyclohydrolase I feedback regulator		decreases expression	EXP	3	105,683,288	105,687,349	RGD:6480464	CTD
G	Gnb3	guanine nucleotide binding protein (G protein), beta polypeptide 3		affects response to substance	ISO	4	160,957,524	160,963,226	RGD:6480464	CTD
G	Gng7	guanine nucleotide binding protein (G protein), gamma 7		decreases expression	EXP	7	10,203,112	10,271,719	RGD:6480464	CTD
G	Grk6	G protein-coupled receptor kinase 6		decreases expression	EXP	17	15,220,992	15,236,617	RGD:6480464	CTD
G	Grn	granulin		decreases expression	EXP	10	91,536,135	91,542,239	RGD:6480464	CTD
G	Gsn	gelsolin		increases expression	EXP	3	14,360,245	14,386,313	RGD:6480464	CTD
G	Gsta2	glutathione S-transferase alpha 2		decreases expression	EXP	8	83,299,249	83,312,958	RGD:6480464	CTD
G	Gsta3	glutathione S-transferase alpha 3		affects metabolic processing	EXP	9	20,005,570	20,032,031	RGD:6480464	CTD
G	Gstm2	glutathione S-transferase mu 2		affects metabolic processing	EXP	2	203,549,022	203,553,380	RGD:6480464	CTD
G	Gtf3c1	general transcription factor IIIC, polypeptide 1, alpha		increases expression	EXP	1	184,701,886	184,768,061	RGD:6480464	CTD
G	Gucy1a3	guanylate cyclase 1, soluble, alpha 3		increases expression	EXP	2	173,756,824	173,818,316	RGD:6480464	CTD
G	Gucy1b3	guanylate cyclase 1, soluble, beta 3		increases expression	EXP	2	173,683,153	173,735,298	RGD:6480464	CTD
G	Gucy1b3	guanylate cyclase 1, soluble, beta 3		increases expression	ISO	2	173,683,153	173,735,298	RGD:6480464	CTD
G	Gucy1b3	guanylate cyclase 1, soluble, beta 3		increases expression	EXP	2	173,683,153	173,735,298	RGD:6480464	CTD
G	Gucy1b3	guanylate cyclase 1, soluble, beta 3		increases expression	EXP	2	173,683,153	173,735,298	RGD:6480464	CTD
G	Hbb	hemoglobin, beta		increases expression	EXP	1	161,618,782	161,620,193	RGD:6480464	CTD
G	Hdc	histidine decarboxylase		decreases expression	EXP	3	114,119,316	114,138,107	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		increases expression	ISO	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		increases expression	ISO	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		multiple interactions	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hmox1	heme oxygenase (decycling) 1		increases expression	EXP	19	13,963,139	13,969,960	RGD:6480464	CTD
G	Hpn	hepsin		increases expression	EXP	1	86,145,615	86,161,091	RGD:6480464	CTD
G	Iapp	islet amyloid polypeptide		increases expression	EXP	4	179,855,956	179,860,871	RGD:6480464	CTD
G	Id2	inhibitor of DNA binding 2		increases expression	EXP	6	42,781,476	42,783,307	RGD:6480464	CTD
G	Il1b	interleukin 1 beta		increases expression	EXP	3	116,964,422	116,970,867	RGD:6480464	CTD
G	Il6	interleukin 6		increases expression	ISO	4	456,799	461,376	RGD:6480464	CTD
G	Il6	interleukin 6		increases expression	EXP	4	456,799	461,376	RGD:6480464	CTD
G	Irs3	insulin receptor substrate 3		increases expression	EXP	12	19,709,141	19,711,279	RGD:6480464	CTD
G	Jtb	jumping translocation breakpoint		increases expression	EXP	2	182,471,061	182,476,268	RGD:6480464	CTD
G	Kng2	kininogen 2		decreases expression	EXP				RGD:6480464	CTD
G	Maob	monoamine oxidase B		increases expression	EXP	X	17,553,529	17,657,852	RGD:6480464	CTD
G	Mecr	mitochondrial trans-2-enoyl-CoA reductase		decreases expression	EXP	5	150,700,130	150,725,219	RGD:6480464	CTD
G	Mgll	monoglyceride lipase		multiple interactions	EXP	4	122,822,493	122,922,892	RGD:6480464	CTD
G	Mgll	monoglyceride lipase		increases activity	EXP	4	122,822,493	122,922,892	RGD:6480464	CTD
G	Mmp2	matrix metallopeptidase 2		increases expression	ISO	19	15,246,036	15,275,061	RGD:6480464	CTD
G	Mmp7	matrix metallopeptidase 7		increases expression	ISO	8	4,526,018	4,533,730	RGD:6480464	CTD
G	Mmp9	matrix metallopeptidase 9		increases activity	ISO	3	155,985,473	155,993,433	RGD:6480464	CTD
G	Mmp9	matrix metallopeptidase 9		increases expression	ISO	3	155,985,473	155,993,433	RGD:6480464	CTD
G	Mpo	myeloperoxidase		decreases activity	EXP	10	76,085,872	76,097,012	RGD:6480464	CTD
G	Mxi1	MAX interactor 1, dimerization protein		increases expression	EXP	1	259,219,584	259,259,979	RGD:6480464	CTD
G	Myo9b	myosin IXb		decreases expression	EXP	16	18,434,261	18,519,220	RGD:6480464	CTD
G	Ncam1	neural cell adhesion molecule 1		increases expression	EXP	8	52,822,350	53,120,572	RGD:6480464	CTD
G	Ndufa5	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 5		decreases expression	EXP	4	50,649,500	50,657,858	RGD:6480464	CTD
G	Nkx2-1	NK2 homeobox 1		decreases expression	EXP	6	76,916,943	76,920,133	RGD:6480464	CTD
G	Nnat	neuronatin		increases expression	EXP	3	148,269,404	148,271,781	RGD:6480464	CTD
G	Nos1	nitric oxide synthase 1, neuronal		multiple interactions	EXP	12	39,812,500	39,869,484	RGD:6480464	CTD
G	Nos1	nitric oxide synthase 1, neuronal		multiple interactions	EXP	12	39,812,500	39,869,484	RGD:6480464	CTD
G	Nos1	nitric oxide synthase 1, neuronal		increases expression	EXP	12	39,812,500	39,869,484	RGD:6480464	CTD
G	Nos1	nitric oxide synthase 1, neuronal		increases expression	EXP	12	39,812,500	39,869,484	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		decreases expression	ISO	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		multiple interactions	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		increases expression	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos2	nitric oxide synthase 2, inducible		decreases expression	EXP	10	65,036,884	65,072,453	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		multiple interactions	EXP	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		multiple interactions	EXP	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		increases expression	EXP	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		increases expression	EXP	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		increases expression	EXP	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		increases expression	EXP	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Nox1	NADPH oxidase 1		decreases expression	EXP				RGD:6480464	CTD
G	Nox4	NADPH oxidase 4		decreases expression	EXP	1	143,415,816	143,603,554	RGD:6480464	CTD
G	Npy	neuropeptide Y		increases expression	EXP	4	78,038,013	78,045,187	RGD:6480464	CTD
G	Paics	phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase		increases expression	EXP	14	33,492,707	33,509,389	RGD:6480464	CTD
G	Parp1	poly (ADP-ribose) polymerase 1		decreases expression	ISO	13	96,309,670	96,341,486	RGD:6480464	CTD
G	Pcsk1n	proprotein convertase subtilisin/kexin type 1 inhibitor		decreases expression	EXP	X	26,614,585	26,618,027	RGD:6480464	CTD
G	Pde1a	phosphodiesterase 1A, calmodulin-dependent		increases expression	EXP	3	62,650,092	62,928,487	RGD:6480464	CTD
G	Pde1a	phosphodiesterase 1A, calmodulin-dependent		multiple interactions	EXP	3	62,650,092	62,928,487	RGD:6480464	CTD
G	Pde2a	phosphodiesterase 2A, cGMP-stimulated		increases expression	EXP	1	158,921,607	159,013,829	RGD:6480464	CTD
G	Pla2g1b	phospholipase A2, group IB, pancreas		increases expression	EXP	12	42,405,475	42,415,189	RGD:6480464	CTD
G	Plaur	plasminogen activator, urokinase receptor		increases expression	EXP	1	79,708,646	79,712,881	RGD:6480464	CTD
G	Pmp22	peripheral myelin protein 22		decreases expression	EXP	10	49,305,835	49,335,864	RGD:6480464	CTD
G	Polr1b	polymerase (RNA) I polypeptide B		increases expression	EXP	3	116,706,483	116,730,946	RGD:6480464	CTD
G	Ppp2cb	protein phosphatase 2, catalytic subunit, beta isozyme		decreases expression	EXP	16	62,330,513	62,351,968	RGD:6480464	CTD
G	Prkg1	protein kinase, cGMP-dependent, type 1		decreases expression	EXP	1	234,420,597	235,765,375	RGD:6480464	CTD
G	Ptgds	prostaglandin D2 synthase (brain)		increases expression	EXP	3	3,632,683	3,635,617	RGD:6480464	CTD
G	Ptprr	protein tyrosine phosphatase, receptor type, R		increases expression	EXP	7	55,324,246	55,612,945	RGD:6480464	CTD
G	Rab40c	Rab40c, member RAS oncogene family		increases expression	EXP	10	15,147,861	15,181,653	RGD:6480464	CTD
G	Reg3b	regenerating islet-derived 3 beta		increases expression	EXP	4	112,355,773	112,359,011	RGD:6480464	CTD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)		increases localization	EXP	1	208,262,669	208,273,148	RGD:6480464	CTD
G	Rela	v-rel reticuloendotheliosis viral oncogene homolog A (avian)		multiple interactions	EXP	1	208,262,669	208,273,148	RGD:6480464	CTD
G	Ren	renin		increases activity	ISO	13	46,262,936	46,275,213	RGD:6480464	CTD
G	Rgs8	regulator of G-protein signaling 8		increases expression	EXP	13	68,735,814	68,766,956	RGD:6480464	CTD
G	Rheb	Ras homolog enriched in brain		decreases expression	EXP				RGD:6480464	CTD
G	Rps3a	ribosomal protein S3a		increases expression	EXP	2	178,092,351	178,096,720	RGD:6480464	CTD
G	Scgb1a1	secretoglobin, family 1A, member 1 (uteroglobin)		decreases expression	EXP	1	211,758,103	211,761,651	RGD:6480464	CTD
G	Sdc4	syndecan 4		decreases expression	EXP	3	155,446,138	155,464,825	RGD:6480464	CTD
G	Serpina3n	serine (or cysteine) peptidase inhibitor, clade A, member 3N		decreases expression	EXP	6	128,461,775	128,469,309	RGD:6480464	CTD
G	Shank2	SH3 and multiple ankyrin repeat domains 2		increases expression	EXP	1	204,399,856	204,855,474	RGD:6480464	CTD
G	Slc4a4	solute carrier family 4, sodium bicarbonate cotransporter, member 4		increases expression	EXP	14	20,381,545	20,739,216	RGD:6480464	CTD
G	Snn	stannin		decreases expression	EXP	10	4,486,038	4,494,711	RGD:6480464	CTD
G	Snrk	SNF related kinase		increases expression	EXP	8	121,958,351	121,968,989	RGD:6480464	CTD
G	Sod2	superoxide dismutase 2, mitochondrial		multiple interactions	EXP	1	41,862,997	41,870,327	RGD:6480464	CTD
G	Stat3	signal transducer and activator of transcription 3 (acute-phase response factor)		increases expression	EXP	10	89,821,078	89,872,970	RGD:6480464	CTD
G	Syk	spleen tyrosine kinase		increases expression	EXP	17	18,440,672	18,498,001	RGD:6480464	CTD
G	Syn2	synapsin II		increases expression	EXP	4	151,255,241	151,413,220	RGD:6480464	CTD
G	Tac1	tachykinin, precursor 1		affects expression	EXP	4	32,649,666	32,657,632	RGD:6480464	CTD
G	Tcf4	transcription factor 4		multiple interactions	ISO	18	66,135,863	66,359,984	RGD:6480464	CTD
G	Thy1	Thy-1 cell surface antigen		decreases expression	EXP	8	47,027,721	47,031,857	RGD:6480464	CTD
G	Tmpo	thymopoietin		increases expression	EXP	7	28,086,576	28,111,800	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		decreases expression	ISO	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		multiple interactions	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnf	tumor necrosis factor		decreases expression	EXP	20	3,661,000	3,663,618	RGD:6480464	CTD
G	Tnfrsf8	tumor necrosis factor receptor superfamily, member 8		decreases expression	EXP	5	163,716,462	163,762,235	RGD:6480464	CTD
G	Umod	uromodulin		increases expression	EXP	1	177,729,212	177,742,552	RGD:6480464	CTD
G	Uox	urate oxidase		decreases expression	EXP	2	244,795,552	244,832,143	RGD:6480464	CTD
G	Vasp	vasodilator-stimulated phosphoprotein		multiple interactions	ISO	1	78,621,494	78,636,762	RGD:6480464	CTD
G	Vasp	vasodilator-stimulated phosphoprotein		increases phosphorylation	ISO	1	78,621,494	78,636,762	RGD:6480464	CTD
G	Vasp	vasodilator-stimulated phosphoprotein		multiple interactions	EXP	1	78,621,494	78,636,762	RGD:6480464	CTD
G	Vasp	vasodilator-stimulated phosphoprotein		multiple interactions	EXP	1	78,621,494	78,636,762	RGD:6480464	CTD
G	Vasp	vasodilator-stimulated phosphoprotein		decreases phosphorylation	EXP	1	78,621,494	78,636,762	RGD:6480464	CTD
G	Vasp	vasodilator-stimulated phosphoprotein		increases phosphorylation	EXP	1	78,621,494	78,636,762	RGD:6480464	CTD
G	Vasp	vasodilator-stimulated phosphoprotein		increases phosphorylation	EXP	1	78,621,494	78,636,762	RGD:6480464	CTD
G	Vasp	vasodilator-stimulated phosphoprotein		decreases phosphorylation	EXP	1	78,621,494	78,636,762	RGD:6480464	CTD
G	Vasp	vasodilator-stimulated phosphoprotein		increases phosphorylation	ISO	1	78,621,494	78,636,762	RGD:6480464	CTD
G	Vtn	vitronectin		increases expression	EXP	10	64,609,242	64,612,322	RGD:6480464	CTD
G	Ywhaz	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide		decreases expression	EXP	7	72,283,825	72,306,126	RGD:6480464	CTD
oxytocin
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Fos	FBJ osteosarcoma oncogene		increases expression	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Fos	FBJ osteosarcoma oncogene		multiple interactions	EXP	6	109,559,135	109,562,001	RGD:6480464	CTD
G	Mknk2	MAP kinase-interacting serine/threonine kinase 2		multiple interactions	EXP	7	10,550,040	10,561,100	RGD:6480464	CTD
G	Noxo1	NADPH oxidase organizer 1		multiple interactions	EXP	10	13,949,293	13,953,880	RGD:6480464	CTD
G	Oxtr	oxytocin receptor		multiple interactions	EXP	4	148,314,089	148,326,797	RGD:6480464	CTD
G	Plcb1	phospholipase C, beta 1 (phosphoinositide-specific)		affects localization	ISO	3	122,797,718	123,523,675	RGD:6480464	CTD
G	Plcb3	phospholipase C, beta 3 (phosphatidylinositol-specific)		affects localization	ISO	1	209,628,425	209,643,694	RGD:6480464	CTD
sucrose
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Agt	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		multiple interactions	EXP	19	54,738,556	54,750,349	RGD:6480464	CTD
G	Agtr1a	angiotensin II receptor, type 1a		multiple interactions	EXP	17	40,629,318	40,684,982	RGD:6480464	CTD
G	Casp3	caspase 3		increases activity	ISO	16	48,944,226	48,962,420	RGD:6480464	CTD
G	Creb1	cAMP responsive element binding protein 1		increases phosphorylation	EXP	9	63,170,785	63,234,727	RGD:6480464	CTD
G	Cyp1a1	cytochrome P450, family 1, subfamily a, polypeptide 1		decreases expression	EXP	8	61,462,207	61,468,237	RGD:6480464	CTD
G	Cyp4a1	cytochrome P450, family 4, subfamily a, polypeptide 1		multiple interactions	EXP	5	135,901,653	135,915,754	RGD:6480464	CTD
G	Cyp4a2	cytochrome P450, family 4, subfamily a, polypeptide 2		multiple interactions	EXP	5	135,765,673	135,773,006	RGD:6480464	CTD
G	Fas	Fas (TNF receptor superfamily, member 6)		multiple interactions	EXP	1	238,259,443	238,274,745	RGD:6480464	CTD
G	G6pc	glucose-6-phosphatase, catalytic subunit		increases expression	EXP	10	90,393,531	90,403,485	RGD:6480464	CTD
G	Gnat3	guanine nucleotide binding protein, alpha transducing 3		affects response to substance	ISO	4	12,785,190	12,834,880	RGD:6480464	CTD
G	Gsk3a	glycogen synthase kinase 3 alpha		decreases phosphorylation	EXP	1	80,505,517	80,514,139	RGD:6480464	CTD
G	Ins2	insulin 2		increases expression	ISO	1	202,935,548	202,936,379	RGD:6480464	CTD
G	Lct	lactase		increases expression	EXP	13	40,990,315	41,043,388	RGD:6480464	CTD
G	Ldlr	low density lipoprotein receptor		multiple interactions	EXP	8	20,824,040	20,846,920	RGD:6480464	CTD
G	Lepr	leptin receptor		affects abundance	ISO	5	122,320,075	122,503,449	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	ISO	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk1	mitogen activated protein kinase 1		multiple interactions	EXP	11	85,968,732	86,030,387	RGD:6480464	CTD
G	Mapk14	mitogen activated protein kinase 14		multiple interactions	ISO	20	6,939,249	7,000,378	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	ISO	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Mapk3	mitogen activated protein kinase 3		multiple interactions	EXP	1	185,935,044	185,941,245	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		multiple interactions	EXP	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Nos3	nitric oxide synthase 3, endothelial cell		decreases expression	EXP	4	6,158,847	6,179,441	RGD:6480464	CTD
G	Ppara	peroxisome proliferator activated receptor alpha		multiple interactions	EXP	7	123,729,774	123,807,090	RGD:6480464	CTD
G	Prkg1	protein kinase, cGMP-dependent, type 1		decreases expression	EXP	1	234,420,597	235,765,375	RGD:6480464	CTD
G	Ptgs2	prostaglandin-endoperoxide synthase 2		multiple interactions	EXP	13	64,427,288	64,432,978	RGD:6480464	CTD
G	Rac1	ras-related C3 botulinum toxin substrate 1		increases activity	ISO	12	11,380,314	11,400,531	RGD:6480464	CTD
G	Rxra	retinoid X receptor alpha		multiple interactions	EXP	3	6,605,782	6,689,224	RGD:6480464	CTD
G	Scarb1	scavenger receptor class B, member 1		multiple interactions	EXP	12	32,390,183	32,457,661	RGD:6480464	CTD
G	Scd1	stearoyl-Coenzyme A desaturase 1		increases activity	EXP	1	249,458,860	249,471,460	RGD:6480464	CTD
G	Scd1	stearoyl-Coenzyme A desaturase 1		increases expression	EXP	1	249,458,860	249,471,460	RGD:6480464	CTD
G	Si	sucrase-isomaltase (alpha-glucosidase)		increases expression	EXP	2	163,520,975	163,601,280	RGD:6480464	CTD
G	Si	sucrase-isomaltase (alpha-glucosidase)		increases expression	EXP	2	163,520,975	163,601,280	RGD:6480464	CTD
G	Slc2a2	solute carrier family 2 (facilitated glucose transporter), member 2		increases expression	EXP	2	116,036,501	116,065,834	RGD:6480464	CTD
G	Slc2a5	solute carrier family 2 (facilitated glucose/fructose transporter), member 5		increases expression	EXP	5	167,240,442	167,285,761	RGD:6480464	CTD
G	Slc2a5	solute carrier family 2 (facilitated glucose/fructose transporter), member 5		increases expression	EXP	5	167,240,442	167,285,761	RGD:6480464	CTD
G	Slc39a4	solute carrier family 39 (zinc transporter), member 4		multiple interactions	ISO	7	114,661,925	114,666,098	RGD:6480464	CTD
G	Slc5a1	solute carrier family 5 (sodium/glucose cotransporter), member 1		increases expression	EXP	14	83,311,232	83,370,657	RGD:6480464	CTD
G	Slc5a1	solute carrier family 5 (sodium/glucose cotransporter), member 1		increases expression	EXP	14	83,311,232	83,370,657	RGD:6480464	CTD
G	Sod1	superoxide dismutase 1, soluble		multiple interactions	EXP	11	29,810,766	29,816,342	RGD:6480464	CTD
G	Tac1	tachykinin, precursor 1		multiple interactions	EXP	4	32,649,666	32,657,632	RGD:6480464	CTD
G	Tacr1	tachykinin receptor 1		multiple interactions	EXP	4	116,610,595	116,780,394	RGD:6480464	CTD
G	Tas1r3	taste receptor, type 1, member 3		multiple interactions	ISO	5	172,718,551	172,721,704	RGD:6480464	CTD
G	Tp53	tumor protein p53		multiple interactions	ISO	10	56,399,721	56,411,150	RGD:6480464	CTD
G	Vasp	vasodilator-stimulated phosphoprotein		multiple interactions	EXP	1	78,621,494	78,636,762	RGD:6480464	CTD
G	Vasp	vasodilator-stimulated phosphoprotein		decreases phosphorylation	EXP	1	78,621,494	78,636,762	RGD:6480464	CTD
trimethylamine N-oxide
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Mbp	myelin basic protein		multiple interactions	ISO	18	78,943,608	79,057,329	RGD:6480464	CTD
G	Slco1a4	solute carrier organic anion transporter family, member 1a4		affects abundance	ISO				RGD:6480464	CTD
triolein
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Abca1	ATP-binding cassette, subfamily A (ABC1), member 1		decreases expression	ISO	5	70,493,357	70,583,729	RGD:6480464	CTD
G	Abcg5	ATP-binding cassette, subfamily G (WHITE), member 5		decreases expression	ISO	6	8,027,647	8,064,425	RGD:6480464	CTD
G	Abcg8	ATP-binding cassette, subfamily G (WHITE), member 8		decreases expression	ISO	6	8,064,631	8,083,271	RGD:6480464	CTD
G	Acaca	acetyl-CoA carboxylase alpha		multiple interactions	ISO	10	72,483,772	72,677,134	RGD:6480464	CTD
G	Cyp27a1	cytochrome P450, family 27, subfamily a, polypeptide 1		decreases expression	ISO	9	74,039,204	74,068,648	RGD:6480464	CTD
G	Fasn	fatty acid synthase		multiple interactions	ISO				RGD:6480464	CTD
G	Hmgcr	3-hydroxy-3-methylglutaryl-CoA reductase		increases expression	ISO	2	27,127,504	27,149,580	RGD:6480464	CTD
G	Mttp	microsomal triglyceride transfer protein		increases expression	ISO	2	235,613,710	235,654,848	RGD:6480464	CTD
G	Npc1l1	NPC1-like 1		decreases expression	ISO				RGD:6480464	CTD
G	Scd1	stearoyl-Coenzyme A desaturase 1		multiple interactions	ISO	1	249,458,860	249,471,460	RGD:6480464	CTD
G	Srebf1	sterol regulatory element binding transcription factor 1		multiple interactions	ISO	10	46,461,684	46,483,646	RGD:6480464	CTD
vasopressin
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	Cftr	cystic fibrosis transmembrane conductance regulator		increases activity	ISO	4	43,874,852	44,041,870	RGD:6480464	CTD
G	Mylk	myosin light chain kinase		affects response to substance	EXP	11	67,602,540	67,848,794	RGD:6480464	CTD

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	492574
role	482262
application +	245197
biological role +	480454
chemical role +	208077